FORM 10-Q

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
(Mark One)

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended SEPTEMBER 30, 1995

OR

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____ to ____

Commission file number 1-9585

ABIOMED, INC.
(Exact name of registrant as specified in its charter)

     DELAWARE                                               04-2743260
     --------                                               ----------
(State of incorporation)                               (I.R.S. Employer No.)

                             33 CHERRY HILL DRIVE
                         DANVERS, MASSACHUSETTS 01923
                         ----------------------------

(Address of principal executive offices, including zip code)

(508) 777-5410

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) or the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X] No [_]

As of September 30, 1995, there were 5,513,833 shares outstanding of the registrant's Common Stock, $.01 par value, and 1,428,000 shares outstanding of the registrant's Class A Common Stock, $.01 par value.


ABIOMED, INC. AND SUBSIDIARIES

TABLE OF CONTENTS

                                                                  Page No.
                                                                  --------
Part I - Financial Information:

 Item 1.  Financial Statements


     Consolidated Balance Sheets
          September 30, 1995 and March 31, 1995                      3-4

     Consolidated Statements of Operations
          Three and Six Months Ended September 30, 1995
          and  September 30, 1994                                      5

     Consolidated Statements of Cash Flows
          Six Months Ended September 30, 1995
          and September 30, 1994                                       6

     Notes to Consolidated Financial Statements                      7-9

 Item 2.  Management's Discussion and Analysis of
         Financial Condition and Results of
         Operations                                                10-13

Part II - Other Information                                        14-15

     Signatures                                                       16

-2-

ABIOMED, INC. AND SUBSIDIARIES

PART 1. FINANCIAL INFORMATION

ITEM 1: FINANCIAL STATEMENTS

CONSOLIDATED BALANCE SHEETS

ASSETS

                                                         September 30, 1995            March 31, 1995
                                                         -------------------        -------------------
                                                             (unaudited)                 (audited)
Current Assets:
  Cash and cash equivalents (Note 6)                                $333,775                   $614,091
  Short-term investments (Note 6)                                  9,483,593                  3,876,943
  Accounts receivable, net                                         2,340,771                  1,775,734
  Inventories (Note 3)                                             1,253,351                  1,409,280
  Prepaid expense and other current asset                            239,854                     53,830
                                                         -------------------        -------------------

          Total  current assets                                   13,651,344                  7,729,878
                                                         -------------------        -------------------

Investments (Note 6):
  Long-term marketable securities                                    662,536                  6,533,490
                                                         -------------------        -------------------

Property and equipment, at cost
  Machinery and equipment                                          2,254,268                  2,189,139
  Furniture and fixtures                                             129,267                    122,934
  Leasehold improvements                                             308,178                    279,181
                                                         -------------------        -------------------
                                                                   2,691,713                  2,591,254

  Less: Accumulated depreciation
    and amortization                                               2,218,449                  2,124,234
                                                                     473,264                    467,020
                                                         -------------------        -------------------

Other Assets:
  Investment in Abiomed Limited
    Partnership, net (Note 7)                                        698,462                          -
                                                         -------------------        -------------------
                                                                 $15,485,606                $14,730,388
                                                         ===================        ===================

The accompanying notes are an integral part of these consolidated financial statements.

-3-

ABIOMED, INC. AND SUBSIDIARIES
PART 1. FINANCIAL INFORMATION
ITEM 1: FINANCIAL STATEMENTS (continued)

CONSOLIDATED BALANCE SHEETS (CONTINUED)

LIABILITIES AND STOCKHOLDERS' INVESTMENT

                                                                 September 30, 1995       March 31, 1995

                                                                     (unaudited)             (audited)
                                                                 ------------------      -----------------
Current Liabilities:
  Accounts payable                                                         $702,335               $198,280
  Accrued expenses                                                        1,229,556              1,227,379
                                                                 ------------------      -----------------
          Total current liabilities                                       1,931,891              1,425,659
                                                                 ------------------      -----------------

Stockholders' Investment (Note 4):
  Class B Preferred Stock, $.01 par value-
          Authorized 1,000,000 shares
          Issued and outstanding-none                                             -                      -
  Common Stock, $.01 par value-
          Authorized 25,000,000 shares at September 30, 1995
          Issued and Outstanding-5,513,833 shares at
          September 30, 1995 and 4,885,852 shares at
          March 31, 1995                                                     55,138                 48,859
  Class A Common Stock $.01 par value
          Authorized - 2,346,000 shares
          Issued and Outstanding - 1,428,000 shares at
          September 30, 1995 and 2,040,000 shares at
          March 31, 1995                                                     14,280                 20,400
  Additional paid-in capital                                             36,593,088             36,476,770
  Accumulated deficit                                                   (23,108,791)           (23,241,300)
                                                                 ------------------      -----------------
          Total stockholders' investment                                 13,553,715             13,304,729
                                                                 ------------------      -----------------
                                                                        $15,485,606            $14,730,388
                                                                 ==================      =================

The accompanying notes are an integral part of these consolidated financial statements.

-4-

ABIOMED, INC. AND SUBSIDIARIES
PART 1. FINANCIAL INFORMATION
ITEM 1: FINANCIAL STATEMENTS (continued)

CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)

                                                      Six Months Ended                             Three Months Ended
                                                      ----------------                             ------------------

                                         September 30, 1995      September 30, 1994      September 30, 1995      September 30, 1994
                                        -------------------     -------------------     -------------------     -------------------
Revenues:
  Products and services                          $4,394,792              $2,638,608              $2,270,351              $1,339,629
  Contracts                                       1,455,297               1,162,106                 836,248                 602,382
                                        -------------------     -------------------     -------------------     -------------------
                                                  5,850,089               3,800,714               3,106,599               1,942,011
                                        -------------------     -------------------     -------------------     -------------------
Costs and expenses:
  Cost of products and services                   1,822,769               1,056,759                 907,876                 518,058
  Research and development (including
  costs related to contracts)                     1,519,037               1,141,038                 860,178                 549,447
  Selling, general and administrative             2,631,499               2,125,741               1,414,585               1,078,286
                                        -------------------     -------------------     -------------------     -------------------
                                                  5,973,305               4,323,538               3,182,639               2,145,791
                                        -------------------     -------------------     -------------------     -------------------

Net income (loss) from operations                  (123,216)               (522,824)                (76,040)               (203,780)

Interest and other income                           255,725                 216,238                 124,488                 113,243
                                        -------------------     -------------------     -------------------     -------------------

Net income (loss)                                $  132,509               ($306,586)             $   48,448                ($90,537)
                                        ===================     ===================     ===================     ===================

Net income (loss) per common share
share  (Note 5):                                       $.02                   ($.05)                   $.01                   ($.01)
                                        ===================     ===================     ===================     ===================

Weighted average number of common
and dilutive common equivalent shares
outstanding                                       6,967,191               6,474,016               6,972,429               6,474,183
                                        ===================     ===================     ===================     ===================

The accompanying notes are an integral part of these consolidated financial statements.

-5-

ABIOMED, INC. AND SUBSIDIARIES
PART 1. FINANCIAL INFORMATION
ITEM 1: FINANCIAL STATEMENTS (continued)

CONSOLIDATED STATEMENT OF CASH FLOWS
(unaudited)

                                                                                     Six Months Ended
                                                                                     ----------------

                                                                        September 30, 1995         September 30, 1994
                                                                        ------------------         ------------------
CASH FLOWS FROM OPERATING ACTIVITIES:
  Net income (loss)                                                               $132,509                  ($306,586)
  Adjustments to reconcile net income (loss) to net cash
  (used in) provided by operating activities-
       Depreciation and amortization                                               165,751                    151,009
       Non cash transactions related to Abiomed
         Limited Partnership                                                             -                   (119,794)
       Changes in assets and liabilities-
         Accounts receivable                                                      (565,037)                   422,875
         Inventories                                                               155,929                   (268,886)
         Prepaid expenses and other current assets                                (186,024)                   (87,715)
         Accounts payable                                                          504,055                     77,498
         Accrued expenses                                                            2,177                   (361,789)
                                                                        ------------------          -----------------

            Net cash (used in) provided by  operating activities                   209,360                   (493,388)
                                                                        ------------------          -----------------

CASH FLOWS FROM INVESTING ACTIVITIES:
  (Purchases) sales of investments, net                                            264,303                    396,238
  Purchases and improvements of property and equipment                            (100,458)                   (35,494)
  Purchases of limited partner units (Note 7)                                     (770,000)                         -
                                                                        ------------------          -----------------

            Net cash (used in) provided by investing activities                   (606,155)                   360,744
                                                                        ------------------          -----------------

CASH FLOWS FROM FINANCING ACTIVITIES:
  Proceeds from exercise of stock options and stock issued
    under employee stock purchase plan                                             116,479                      8,858
                                                                        ------------------          -----------------

            Net cash provided by financing activities                              116,479                      8,858
                                                                        ------------------          -----------------

NET DECREASE IN CASH AND EQUIVALENTS,
  EXCLUDING INVESTMENTS                                                           (280,316)                  (123,786)

CASH AND CASH EQUIVALENTS, EXCLUDING INVEST-
  MENTS, AT BEGINNING OF PERIOD                                                    614,091                    480,058
                                                                        ------------------          -----------------
CASH AND CASH EQUIVALENTS , EXCLUDING INVEST-
  MENTS, AT END OF PERIOD                                                        $ 333,775                 $  356,272
                                                                        ==================          =================

The accompanying notes are an integral part of these consolidated financial statements.

-6-

ABIOMED, INC. AND SUBSIDIARIES
PART 1. FINANCIAL INFORMATION (continued)
ITEM 1: FINANCIAL STATEMENTS (continued)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

1. Basis of Preparation

The unaudited consolidated financial statements of ABIOMED, Inc. (the Company), presented herein have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and note disclosures required by generally accepted accounting principles. These statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company's latest audited financial statements, which are contained in the Company's Form 10-K for the year ended March 31, 1995, which was filed with the Securities and Exchange Commission. In the opinion of management, the accompanying consolidated financial statements include all adjustments (consisting only of normal recurring adjustments) necessary to summarize fairly the Company's financial position and results of operations. The results of operations for the six months ended September 30, 1995 may not be indicative of the results that may be expected for the full fiscal year.

2. Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, ABIOMED Cardiovascular, Inc., ABIOMED R&D Inc., ABIODENT, Inc., Abiomed Research and Development, Inc., ABD Holding Company, Inc., and the accounts of its majority-owned subsidiary Abiomed Limited Partnership (see Note 7). All significant intercompany accounts and transactions have been eliminated in consolidation.

3. Inventories

Inventories include raw materials, work-in-process, and finished goods and are priced at the lower of cost (first-in, first-out) or market and consist of the following:

                   September 30,        March 31,
                       1995                1995
                   -------------      ------------

Raw Materials       $  457,702         $  339,686
Work-in-Process        485,534            412,956
Finished goods         310,115            656,638
                    ----------         ----------

TOTAL               $1,253,351         $1,409,280
                    ==========         ==========

Finished goods and work-in-process inventories consist of direct material, labor, and overhead.

-7-

ABIOMED, INC. AND SUBSIDIARIES
PART 1. FINANCIAL INFORMATION (continued)
ITEM 1: FINANCIAL STATEMENTS (continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited, continued)

4. Stockholders' Investment

On August 9, 1995, the Stockholders of the Company voted to increase the number of authorized shares of Common Stock from 10,000,000 to 25,000,000 shares.

Effective August 10, 1995, in accordance with the rights for the Class A Common Stock, 612,000 shares of Class A Common Stock $.01 par value were converted into an equal number of shares of the Company's $.01 par value Common Stock.

During the second quarter of fiscal 1996, options to purchase 13,500 shares of Common Stock were granted with an exercise price of $7.50 per share. Options to purchase 2,000 shares were canceled during the quarter. Options to purchase 15,450 shares were exercised in the second quarter at exercise prices ranging from $5.75 to $8.50 per share. A total of 531 shares of Common Stock were issued under the Company's Employee Stock Purchase Plan.

5. Net Income (Loss) Per Common Share

Net income (loss) per common share has been computed by dividing the net income (loss) by the weighted average number of common and common equivalent shares outstanding during the period. Common equivalent shares, such as stock options, have not been included in the per share calculation where the effect of their inclusion would be antidilutive. No common equivalent shares are considered dilutive in periods, such as the three and six month periods ended September 30, 1994, in which a loss is reported because all such common equivalent shares are antidilutive.

6. Cash and Cash Equivalents

The Company classifies any marketable security with a maturity date of 90 days or less at the time of acquisition to be a cash equivalent. Securities, including marketable securities, with original maturities of greater than 90 days are classified as investments. Such investments are classified as long-term investments when their maturities are greater than one year from the balance sheet date. The company reports investments at cost plus accrued interest.

7. ABIOMED Limited Partnership

Abiomed Limited Partnership (the Partnership) was formed in March 1985 and provided initial funding for the design and development of two of the Company's products, the BVS and SupraCor (the Products). Today, the Partnership is inactive except for certain royalty rights, described below, on the Company's sales of the Products.

-8-

ABIOMED, INC. AND SUBSIDIARIES
PART 1. FINANCIAL INFORMATION (continued)
ITEM 1: FINANCIAL STATEMENTS (continued)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited, continued)

7. ABIOMED Limited Partnership (continued)

The Partnership consists of a sole general partner, which is the Company's wholly owned subsidiary, Abiomed Research and Development, Inc.; a special limited partner, which is the Company's wholly owned subsidiary ABIOMED Cardiovascular, Inc. (Cardiovascular); and one hundred thirty-five limited partner units. As of March 31, 1995 the Company held a 10.9% interest in the Partnership comprised of 1.0% by the general partner and 9.9% by the special limited partner while each of the limited partner units were owned by third party investor limited partners. The limited partner units aggregate to hold an 89.1% interest in the Partnership.

In May 1995, the Company made an offer to purchase each of the one hundred thirty-five limited partner units for $10,000 each. As of September 30, 1995 seventy-seven limited partner units had been tendered to the Company under this offer. The Company paid $770,000 with respect to these tenders through the six months ended September 30, 1995. Combined with the Company's initial 10.9% ownership, the Company now owns 61.7% of the Partnership. The Company's purchase of these limited partner units has been treated as a long-term asset and is being amortized over 5 years.

In March 1995, the Company satisfied all of its remaining fixed obligations to the Partnership. Commencing April 1, 1995 and ending August 3, 2000, the Company owes a royalty to the Partnership of 5.5% of certain revenues from the Products made during the period. Because the Company owns 61.7% of the Partnership, the net royalty to the Company is approximately 2.1%. This royalty formula is subject to certain maximum amounts and to certain additional adjustments in the event that the Company sells the technology.

-9-

ABIOMED, INC. AND SUBSIDIARIES
PART 1. FINANCIAL INFORMATION (continued)

ITEM 2: MANAGEMENT'S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

RESULTS OF OPERATIONS

NET INCOME (LOSS)

Net income and income per share for the three months ended September 30, 1995 were approximately $49,000 and $.01 per share, respectively. These earnings compare to a net loss and loss per share of approximately $91,000 and $.01 per share, respectively, in the same period of the previous year.

Net income and income per share for the six months ended September 30, 1995 were approximately $133,000 and $.02 per share, respectively. These earnings compare to a loss of approximately $307,000 and $.05 per share in the same period of the previous year.

REVENUES

In the three months ended September 30, 1995, total revenues were approximately $3,107,000, 60% higher than total revenues of approximately $1,942,000 in the same period of the previous year.

Product and service revenues were approximately $2,270,000, 69% higher than product and service revenues of approximately $1,340,000 in the same period of the previous year. These results primarily reflect increased units sales to new customers and increased units sales of the disposable cardiovascular product to the expanded installed customer base. Revenues from dental products, though growing, represented less than 10% of total revenues for the three months ended September 30, 1995. More than 90% of total product and service revenues were derived from domestic sources.

Revenues from Research and Development (R&D) contracts and grants for this quarter were approximately $836,000, 39% higher than total revenues of approximately $602,000 reported in the same quarter of the previous year. This increase primarily reflects timing of scheduled activities under existing contracts and grants. All such government contracts contain provisions making them terminable at the convenience of the government.

In the six months ended September 30, 1995, total revenues were approximately $5,850,000, 54% higher than total revenues of approximately $3,801,000 in the same period of the previous year.

Product sales for the first six months of fiscal 1996 were $4,395,000 compared with $2,639,000 for the same period of the previous year, an increase of 67%. This growth primarily reflects increased units sales to new customers and increased units sales of the disposable

-10-

ABIOMED, INC. AND SUBSIDIARIES
PART 1. FINANCIAL INFORMATION (continued)

ITEM 2: MANAGEMENT'S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

REVENUES (continued)

cardiovascular product to the expanded installed customer base. Revenues from dental products continued to grow, however, represented less than 10% of total revenue for the six month period.

Revenues from Research and Development (R&D) contacts and grants for the six months ended September 30, 1995 were approximately $1,455,000, 25% higher than in the same period of the prior year. The increase primarily reflects the timing of scheduled activities under existing contracts and grants. All government grants and contracts contain provisions making them terminable at the convenience of the government.

COSTS AND EXPENSES

Total costs and expenses for the three months ended September 30, 1995 were approximately $3,183,000, 48% higher than total costs and expenses of approximately $2,146,000 in the same fiscal quarter of the previous year. The majority of this increase reflects expenses incurred to support higher revenues.

Cost of products sold as a percentage of product sales (40%) was relatively unchanged from the same quarter of the previous year (39%) while increasing in total cost by approximately $390,000. These increased costs reflect higher product revenue levels attained in the current year's quarter.

Total research and development costs increased during the second fiscal quarter of 1996 to approximately $860,000, a 56% increase over research and development costs of approximately $550,000 incurred during the same fiscal period last year. The increase primarily reflects the timing of scheduled expenditures under contracts and grants.

Selling, general and administrative expenses for the three months ended September 30, 1995 increased to $1,415,000, 31% higher than selling, general and administrative expenses in the same fiscal quarter of the previous year. This increase primarily reflects increased sales and marketing expenses, particularly increased personnel and sales commissions, related to the increase in product and service revenues.

Total costs and expenses for the six month period ended September 30, 1995 increased to $5,973,000, 38% higher than total costs and expenses of approximately $4,324,000 for the first six months of last year. The increase is primarily attributable to higher revenue levels attained during the first six months of fiscal 1996.

Cost of products sold as a percentage of products sales (41%) for the six

months ended September 30, 1995 was relatively unchanged from the same six month period ended September

-11-

ABIOMED, INC. AND SUBSIDIARIES
PART 1. FINANCIAL INFORMATION (continued)

ITEM 2: MANAGEMENT'S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

COSTS AND EXPENSES (CONTINUED)

30, 1994 (40%) while increasing in total cost by approximately $766,000. These increased costs primarily reflect higher product revenue levels.

Total research and development costs increased to approximately $1,519,000 for the six months ended September 30, 1995. This represents a 33% increase over the $1,141,000 reported for the same period in the previous fiscal year. The increase primarily reflects the timing of scheduled expenditures under contracts and grants.

Selling, general and administrative expenses for the six months ended September 30, 1995 increased to approximately $2,632,000, 24% higher than selling, general and administrative expenses in six month period ended September 30, 1994. This increase primarily reflects increased sales and marketing expenses, particularly increased personnel and sales commissions, related to the increase in product and service revenues.

INTEREST AND OTHER

Interest and other income increased to approximately $125,000 in the second quarter of 1996 compared with approximately $113,000 in the corresponding quarter of the prior year primarily due to a higher level of cash and investments.

For the six months ended September 30, 1995, interest and other income was approximately $256,000 compared to $216,000 for the six months ended September 30, 1994. This increase was primarily due to a higher level of cash and investments.

LIQUIDITY AND CAPITAL RESOURCES

As of September 30, 1995, the Company's balance sheet included $10,480,000 in cash and investments, a decrease of approximately $545,000 from March 31, 1995. This decrease reflects $770,000 in cash used to purchase limited partner units of the Abiomed Limited Partnership net of approximately $225,000 in cash generated from operations and other activities. The September 30, 1995 balance includes approximately $334,000 in cash, $9,484,000 in short-term investments and $663,000 in investments with various maturities, the latest of which is October 1996. The Company also has a $3,000,000 line of credit from a bank which expires on December 1, 1995, and which was entirely available at September 30, 1995.

Net cash provided by operating activities included net income and depreciation and amortization expenses of approximately $298,000, an increase in accounts payable of $504,000

-12-

ABIOMED, INC. AND SUBSIDIARIES
PART 1. FINANCIAL INFORMATION (continued)

ITEM 2: MANAGEMENT'S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

LIQUIDITY AND CAPITAL RESOURCES (CONTINUED)

and a decrease in inventories of approximately $156,000. These sources of cash were partially offset by an increase in accounts receivable of $565,000 and an increase of prepaid and other current assets of approximately $186,000. The increase in accounts receivable is attributable to increased credit sales and longer collection periods for certain accounts. The decrease in inventory was primarily attributable to a decrease in finished goods inventory due to increased product sales.

Net cash used in investing activities included $770,000 of purchases of limited partner units of Abiomed Limited Partnership (the Partnership) and approximately $100,000 of purchases and improvements of property and equipment which were partially offset by approximately $264,000 of net purchases and maturities of investments. As set forth in Note 7 of the financial statements included in this report, the Company had offered to purchase units of the investor limited partner's interests in the Partnership at a purchase price of $10,000 per unit. As of September 30, 1995 the Company had acquired and paid for seventy-seven (77) units of the Partnership.

HEALTH CARE REFORM

Private and government proposals for significant health care reform are expected to continue to affect healthcare expenditures in the United States as well as internationally where the company sells or plans to sell its products. The Company cannot assess at this time the potential impact that healthcare trends may have on future results because of uncertainties surrounding any unforseeable changes.

***

-13-

ABIOMED, INC. AND SUBSIDIARIES

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

None

Item 2. Changes in Securities

None

Item 3. Defaults upon Senior Securities

None

Item 4. Submission of Matters to a Vote of Security Holders

At the Company's annual meeting of shareholders held on August 9, 1995, the stockholders approved the following:

a) Elected six persons to serve as directors as follows:

                                                       Votes
           Director                   Votes For       Withheld
           --------                   ---------    -------------
Dr. David Lederman (Class I)           4,234,980         140,443
Dr. Gerald W. Austen (Class III)       4,234,980         140,443
Paul Fireman (Class III)               4,229,549         145,874
John F. O'Brien (Class II)             4,234,980         140,443
Henri A. Termeer (Class II)            4,234,480         140,943
Desmond H. O'Connell, Jr. (Class I)    4,338,080          37,343

b) A proposal to amend the Company's certificate of incorporation to provide for the classification of the Board of Directors into three classes of directors with staggered terms of office. The proposal received 1,306,723 votes for and 622,185 against. There were 32,889 abstentions and 2,413,626 non-voting.

c) A proposal to amend the Company's certificate of incorporation regarding the consideration of all relevant factors in connection with certain business combinations. The proposal received 1,383,063 votes for and 594,965 against. There were 47,168 abstentions and 2,350,227 non- voting.

-14-

ABIOMED, INC. AND SUBSIDIARIES

PART II. OTHER INFORMATION

Item 4. Submission of Matters to a Vote of Security Holders (Continued)

d) A proposal to amend the Company's certificate of incorporation to increase the number of shares of the Company's Common Stock authorized thereunder from 10,000,000 to 25,000,000 shares. The proposal received 3,626,244 votes for and 623,689 against. There were 30,100 abstentions and 95,380 non-voting.

e) A proposal to amend the Company's 1992 Combination Stock Option Plan to increase the number of shares that may be issued under that plan. The proposal received 1,274,114 votes for and 660,475 against. There were 27,558 abstentions and 2,413,276 non-voting.

f) A proposal to amend the Company's 1989 Non-Qualified Stock. Option Plan for Non-Employee Directors to increase the number of shares that may be issued under that plan. The proposal received 1,702,116 votes for and 288,878 against. There were 35,902 abstentions and 2,348,527 non-voting.

g) A proposal to act upon any matter incidental to the foregoing purpose and any other matter which may properly come before the Annual Meeting or any adjourned session thereof. There were no such matters acted upon during the Annual Meeting.

Item 5. Other Information

a) None

Item 6. Exhibits and Reports on Form 8-K

a) Exhibits
3.1 Certificate of Amendment of Certificate of Incorporation of ABIOMED, Inc.

3.2 By-laws of ABIOMED, Inc., amended

10.1 ABIOMED, Inc. 1989 Non-Qualified Stock Option Plan for Non-Employee Directors, as amended

-15-

ABIOMED, INC AND SUBSIDIARIES

PART II, OTHER INFORMATION

Item 6. Exhibits and reports on Form 8-k (continued)

10.2 ABIOMED, Inc. 1992 Combination Stock Option Plan, as amended

b) Reports on Form 8-K

Form 8-K dated August 10, 1995.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

ABIOMED, Inc.

Date:   October  26 , 1995             /s/
                                       -------------------------------
                                       David M. Lederman
                                       CEO and President



Date:   October  26 , 1995             /s/
                                       -------------------------------
                                       John F. Thero
                                       Vice President Finance and Administration

-16-

CERTIFICATE OF AMENDMENT

OF

CERTIFICATE OF INCORPORATION

ABIOMED, Inc.

ABIOMED, Inc., a corporation organized and existing under the laws of the State of Delaware (the "Corporation"), pursuant to Section 242 of the Delaware General Corporation Law, hereby certifies as follows:

1. The Board of Directors of the Corporation, at a meeting duly held on June 15, 1995, at which a quorum was present and acting throughout and in accordance with the provisions of Section 242 of the Delaware General Corporation Law, approved the following amendments to the Corporation's Certificate of Incorporation:

i. To increase the number of authorized shares of Common Stock, $.01 par value, from 10,000,000 to 25,000,000 shares.

ii. Paragraphs (c), (d) and (g) of Section 4.2.2 of Article 4 shall be amended to read in their entirety as follows:

(c) Any director elected by the holders of Common Stock voting as a separate class under paragraph (b) above may only be removed for cause by the holders of the Common Stock voting as a separate class. The remaining directors may be removed only for cause by the stockholders voting in accordance with paragraph (a).

(d) So long as there is any Class A Common Stock outstanding, any vacancy in the office of a director electable by the holders of Common Stock voting as a separate class may be filled by a vote of such holders voting as a separate class, and in the absence of such a stockholder vote, such vacancy may be filled by the remaining directors elected by the Common Stock voting as a separate class, and in the absence of any directors so elected, by all the remaining directors. So long as there is any Class A Common Stock outstanding, any vacancy in the office of a director electable by the holders of both classes of common stock voting as a single class shall be filled by the remaining directors elected by both classes, and in the absence of any directors so elected, by the holders of both classes of common stock voting as a single class. At such time as there is no longer any Class A Common Stock outstanding, any vacancy in the office of director shall be filled by the remaining directors, and in the absence of any directors, by the stockholders. Unless the conditions set forth in paragraph (f) exist in respect of the next annual meeting of stockholders, the Board of Directors may be enlarged by the Board of Directors only to the extent that twenty-five percent (25%) of the enlarged Board of Directors consists of directors either (i) elected by the holders of the Common Stock or (ii) appointed by directors elected by the holders of Common Stock voting as a separate class.

(g) This Certificate of Incorporation may be amended to change the powers, preferences, relative voting power or special rights of the shares of the Common Stock or the Class A Common Stock so as to affect either class adversely relative to the other, but any proposal to do so shall require the approval of a


majority of the votes entitled to be cast by the holders of the class adversely affected by the proposed amendment, voting separately as a class, in addition to the approval of a majority of the votes entitled to be cast by the holders of the Common Stock and the Class A Common Stock voting together as a single class as hereinbefore provided. In addition, this Section 4.2.2 shall not be amended, altered or repealed except by the affirmative vote of eighty percent (80%) of the votes entitled to be cast by the stockholders voting in accordance with paragraph (a).

iii. Article 13 shall be added to read in its entirety as follows:

13. CLASSIFIED BOARD OF DIRECTORS

(a) The number of directors of the corporation shall be the number, not less than 3 nor more than 12, fixed from time to time by the Board of Directors. The Board of Directors may be enlarged only by vote of a majority of the directors then in office.

(b) Commencing at the annual meeting of the stockholders in 1995, the directors shall be divided into three classes, designated Class I, Class II and Class III. Each class shall consist, as nearly as may be possible, of one third of the number of directors constituting the entire Board of Directors. At the annual meeting of the stockholders held in 1995, Class I directors shall be elected for a one year term, Class I directors shall be elected for a two year term, and Class III directors shall be elected for a three year term, and in each case until their successors are duly elected and qualified. Commencing in 1996, at each annual meeting of the stockholders successors to the class of directors whose terms expire at that annual meeting of stockholders shall be elected by stockholders for a three year term and until their successors are duly elected and qualified. If the number of directors constituting the entire Board of Directors shall be changed as provided in paragraph (a) of this Article 13, the increase or decrease shall be apportioned among the classes so as to maintain the number of directors in each class as nearly equal as possible.

(c) Any director elected to fill a vacancy resulting from an increase in any class or from the removal from office, death, disability, resignation or disqualification of a director or other cause shall hold office for the remaining term of the class to which such director is elected. No decrease in the size of the Board of Directors shall have the effect of removing or shortening the term of any incumbent director.

(d) Whenever the holders of any series of Preferred Stock issued pursuant to the provisions of Part 4.4 of Article 4 of this certificate of incorporation shall have the right, voting as a separate class, to elect directors, the election, term of office, filling of vacancies and other terms of such directorships shall be governed by the terms of this certificate of incorporation applicable to such series or by the resolution or resolutions of the Board of Directors providing for such series, as the case may be, and such directorships shall not be divided into classes or otherwise subject to this Article 13 unless expressly so provided therein.

(e) This Article 13 shall not be amended, altered or repealed except by the affirmative vote of eighty percent (80%) of the votes entitled to be cast by stockholders voting in accordance with
Section 4.2.2(a) of Article 4.

-2-

iv. Article 14 shall be added to read in its entirety as follows:

14. CONSIDERATION OF RELEVANT FACTORS IN BUSINESS COMBINATIONS.

The Board of Directors of the corporation, when evaluating any offer of another party to (i) purchase or exchange any securities or property for any outstanding equity securities of the corporation, (ii) merge or consolidate the corporation with another corporation, or (iii) purchase or otherwise acquire all or substantially all of the properties and assets of the corporation, shall, in connection with the exercise of its judgment in determining what is in the best interests of the corporation and its stockholders, give due consideration to all relevant factors, including without limitation: (a) not only the price or other consideration being offered in relation to the then current market price of the corporation's outstanding shares of capital stock, but also the Board of Directors' estimate of the future value of the corporation as an independent going concern and the unrealized value of its property and assets; (b) the financial and managerial resources and future prospects of the other party; and (c) the possible social, legal, environmental and economic effects of the transaction on the business of the corporation and its subsidiaries and on the employees, customers, suppliers and creditors of the corporation and its subsidiaries and the effects on the communities in which the corporation's facilities are located. In evaluating any such offer on the basis of the foregoing factors, the directors shall be deemed to be performing their duly authorized duties and acting in good faith and in the best interests of the corporation within the meaning of Section 145 of the General Corporation Law of Delaware, as it may be amended from time to time.

2. The foregoing amendments to the Certificate of Incorporation were duly adopted by the stockholders at a meeting duly held, at which a quorum was present and acting throughout and in accordance with the provisions of Section 242 of the General Corporation Law of Delaware, on August 9, 1995.

IN WITNESS WHEREOF, ABIOMED, Inc. has caused this Certificate of Amendment of its Certificate of Incorporation to be signed by David M. Lederman, its President, and attested to by Donald E. Paulson, its Secretary, this 25th day of October, 1995.

ABIOMED, Inc.

                                       By:    /s/ David M. Lederman
                                            -------------------------------
                                            David M. Lederman,
                                            President

ATTEST:


By:   /s/ Donald E. Paulson
    -------------------------------
    Donald E. Paulson, Secretary

-3-

BY-LAWS

of

ABIOMED, Inc.

A Delaware Corporation

Adopted: June 4, 1987
Amended: July 2, 1990 and
June 15, 1995

   /s/ Donald E. Paulson
---------------------------
         Secretary


BY-LAWS

TABLE OF CONTENTS

                                                                            Page
                                                                            ----
ARTICLE I. - STOCKHOLDERS......................................................1

Section 1.1.  Annual Meeting...................................................1

SECTION 1.2.  SPECIAL MEETINGS.................................................1

Section 1.3.  Notice of Meeting................................................1
Section 1.4.  Quorum...........................................................2
Section 1.5.  Voting and Proxies...............................................2
Section 1.6.  Action at Meeting................................................2
Section 1.7.  Action Without Meeting...........................................2
Section 1.8.  Voting of Shares of Certain Holders..............................2
Section 1.9.  Stockholder Lists................................................3

ARTICLE II. - BOARD OF DIRECTORS...............................................3

Section 2.1.  Powers...........................................................3
Section 2.2.  Number of Directors; Qualifications..............................4
Section 2.3.  Nomination of Directors..........................................4
Section 2.4   Election of Directors............................................4
Section 2.5.  Vacancies; Reduction of the Board................................4
Section 2.6.  Enlargement of the Board.........................................4
Section 2.7.  Tenure and Resignation...........................................5
Section 2.8.  Removal..........................................................5
Section 2.9.  Meetings.........................................................5
Section 2.10.  Notice of Meeting...............................................5
Section 2.11.  Agenda..........................................................5
Section 2.12.  Quorum..........................................................6
Section 2.13.  Action at Meeting...............................................6
Section 2.14.  Action Without Meeting..........................................6
Section 2.15.  Committees......................................................6

ARTICLE III. - OFFICERS........................................................6

Section 3.1.  Enumeration......................................................6
Section 3.2.  Election.........................................................7
Section 3.3.  Qualification....................................................7
Section 3.4.  Tenure...........................................................7
Section 3.5.  Removal..........................................................7
Section 3.6.  Resignation......................................................7
Section 3.7.  Vacancies........................................................7
Section 3.8.  Chairman of the Board............................................7
Section 3.9.  President........................................................7
Section 3.10.  Executive Vice-President; Vice-President(s).....................8
Section 3.11.  Treasurer and Assistant Treasurers..............................8
Section 3.12.  Secretary and Assistant Secretaries.............................8
Section 3.13.  Other Powers and Duties.........................................8

-i-

ARTICLE IV. - CAPITAL STOCK....................................................9

Section 4.1.  Stock Certificates...............................................9
Section 4.2.  Transfer of Shares...............................................9
Section 4.3.  Record Holders...................................................9
Section 4.4.  Record Date......................................................9
Section 4.5.  Transfer Agent and Registrar for Shares of Corporation..........10
Section 4.6.  Loss of Certificates............................................10
Section 4.7.  Restrictions on Transfer........................................11
Section 4.8.  Multiple Classes of Stock.......................................11

ARTICLE V. - DIVIDENDS........................................................11

Section 5.1.  Declaration of Dividends........................................11
Section 5.2.  Reserves........................................................11

ARTICLE VI. - POWERS OF OFFICERS TO CONTRACT WITH THE CORPORATION.............12

ARTICLE VII. - INDEMNIFICATION................................................12

Section 7.1.  Definitions.....................................................12
Section 7.2.  Right to Indemnification in General.............................14
Section 7.3.  Proceedings Other Than Proceedings by or in the Right of the
                Corporation...................................................14
Section 7.4.  Proceedings by or in the Right of the Corporation...............14
Section 7.5.  Indemnification of a Party Who is Wholly or Partly Successful...15
Section 7.6.  Indemnification for Expenses of a Witness.......................15
Section 7.7.  Advancement of Expenses.........................................15
Section 7.8.  Notification and Defense of Claim...............................16
Section 7.9.  Method of Determination.........................................17
Section 7.10.  Presumptions and Effect of Certain Proceedings.................17
Section 7.11.  Non-Exclusivity................................................18
Section 7.12.  Insurance......................................................18
Section 7.13.  No Duplicative Payment.........................................18
Section 7.14.  Severability...................................................18

ARTICLE VIII. - MISCELLANEOUS PROVISIONS......................................19

Section 8.1.  Certificate of Incorporation....................................19
Section 8.2.  Fiscal Year.....................................................19
Section 8.3.  Corporate Seal..................................................19
Section 8.4.  Execution of Instruments........................................19
Section 8.5.  Voting of Securities............................................19
Section 8.6.  Evidence of Authority...........................................19
Section 8.7.  Corporate Records...............................................19
Section 8.8.  Charitable Contributions........................................20

ARTICLE IX. - AMENDMENTS......................................................20

Section 9.1.  Amendment by Stockholders.......................................20
Section 9.2.  Amendment by Board of Directors.................................20

-ii-

BY-LAWS

OF

ABIOMED, Inc.

(A Delaware Corporation)

ARTICLE I

Stockholders

Section 1.1. Annual Meeting. The annual meeting of the stockholders of the corporation shall be held on the first Wednesday of September in each year, at such time and place within or without the State of Delaware as may be designated in the notice of meeting. If the day fixed for the annual meeting shall fall on a legal holiday, the meeting shall be held on the next succeeding day not a legal holiday. If the annual meeting is omitted on the day herein provided, a special meeting may be held in place thereof, and any business transacted at such special meeting in lieu of annual meeting shall have the same effect as if transacted or held at the annual meeting.

Section 1.2. Special Meetings. Special meetings of the stockholders may be called at any time by the chairman of the board of directors, the president or by the board of directors. Special meetings of the stockholders shall be held at such time, date and place within or outside of the State of Delaware as may be designated in the notice of such meeting.

Section 1.3. Notice of Meeting. A written notice stating the place, date, and hour of each meeting of the stockholders, and, in the case of a special meeting, the purposes for which the meeting is called, shall be given to each stockholder entitled to vote at such meeting, and to each stockholder who, under the Certificate of Incorporation or these By-laws, is entitled to such notice, by delivering such notice to such person or leaving it at their residence or usual place of business, or by mailing it, postage prepaid, and addressed to such stockholder at his address as it appears upon the books of the corporation, at least ten (10) days and not more than sixty (60) before the meeting. Such notice shall be given by the secretary, an assistant secretary, or any other officer or person designated either by the secretary or by the person or persons calling the meeting.

The requirement of notice to any stockholder may be waived by a written waiver of notice, executed before or after the meeting by the stockholder or his attorney thereunto duly authorized, and filed with the records of the meeting, or if communication with such stockholder is unlawful, or by attendance at the meeting without protesting prior thereto or at its commencement the lack of notice. A waiver of notice of any regular or special meeting of the stockholders need not specify the purposes of the meeting.

1

If a meeting is adjourned to another time or place, notice need not be given of the adjourned meeting if the time and place are announced at the meeting at which the adjournment is taken, except that if the adjournment is for more than thirty days, or if after the adjournment a new record date is fixed for the adjourned meeting, notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting.

Section 1.4. Quorum. The holders of a majority in interest of all stock issued, outstanding and entitled to vote at a meeting shall constitute a quorum. Any meeting may be adjourned from time to time by a majority of the votes properly cast upon the question, whether or not a quorum is present.

Section 1.5. Voting and Proxies. Stockholders shall have one vote for each share of stock entitled to vote owned by them of record according to the books of the corporation, unless otherwise provided by law or by the Certificate of Incorporation. Stockholders may vote either in person or by written proxy, but no proxy shall be voted or acted upon after three years from its date, unless the proxy provides for a longer period. Proxies shall be filed with the secretary of the meeting, or of any adjournment thereof. Except as otherwise limited therein, proxies shall entitle the persons authorized thereby to vote at any adjournment of such meeting. A proxy purporting to be executed by or on behalf of a stockholder shall be deemed valid unless challenged at or prior to its exercise and the burden of proving invalidity shall rest on the challenger. A proxy with respect to stock held in the name of two or more persons shall be valid if executed by one of them unless at or prior to exercise of the proxy the corporation receives a specific written notice to the contrary from any one of them.

Section 1.6. Action at Meeting. When a quorum is present at any meeting, a plurality of the votes properly cast for election to any office shall elect to such office, and a majority of the votes properly cast upon any question other than election to an office shall decide such question, except where a larger vote is required by law, the Certificate of Incorporation or these by- laws. No ballot shall be required for any election unless requested by a stockholder present or represented at the meeting and entitled to vote in the election.

Section 1.7. Action Without Meeting. Any action required or permitted to be taken at any meeting of the stockholders may be taken without a meeting if the minimum number of stockholders necessary to authorize or take such action and entitled to vote on the matter consent to the action in writing and the consents are filed with the records of the meetings of stockholders. Such consent shall be treated for all purposes as a vote at a meeting.

Section 1.8. Voting of Shares of Certain Holders. Shares of stock of the corporation standing in the name of another corporation, domestic or foreign, may be voted by such officer, agent, or proxy as the by-laws of such corporation may prescribe, or, in the absence of such provision, as the board of directors of such corporation may determine.

2

Shares of stock of the corporation standing in the name of a deceased person, a minor ward or an incompetent person, may be voted by his administrator, executor, court-appointed guardian or conservator without a transfer of such shares into the name of such administrator, executor, court appointed guardian or conservator. Shares of capital stock of the corporation standing in the name of a trustee may be voted by him.

Shares of stock of the corporation standing in the name of a receiver may be voted by such receiver, and shares held by or under the control of a receiver may be voted by such receiver without the transfer thereof into his name if authority so to do be contained in an appropriate order of the court by which such receiver was appointed.

A stockholder whose shares are pledged shall be entitled to vote such shares until the shares have been transferred into the name of the pledgee, and thereafter the pledgee shall be entitled to vote the shares so transferred.

Shares of its own stock belonging to this corporation shall not be voted, directly or indirectly, at any meeting and shall not be counted in determining the total number of outstanding shares at any given time, but shares of its own stock held by the corporation in a fiduciary capacity may be voted and shall be counted in determining the total number of outstanding shares.

Section 1.9. Stockholder Lists. The secretary (or the corporation's transfer agent or other person authorized by these By-laws or by law) shall prepare and make, at least ten days before every meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting, arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in the name of each stockholder. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting, during ordinary business hours, for a period of at least ten days prior to the meeting, either at a place within the city where the meeting is to be held, which place shall be specified in the notice of the meeting, or, if not so specified, at the place where the meeting is to be held. The list shall also be produced and kept at the time and place of the meeting during the whole time thereof, and may be inspected by any stockholder who is present.

ARTICLE II.

Board of Directors

Section 2.1. Powers. Except as reserved to the stockholders by law, by the Certificate of Incorporation or by these By-laws, the business of the corporation shall be managed under the direction of the board of directors, who shall have and may exercise all of the powers of the corporation. In particular, and without limiting the foregoing, the board of directors shall have the power to issue or reserve for issuance from time to time the whole or any part of the capital stock of the corporation which may be authorized from time to time to such person, for such

3

consideration and upon such terms and conditions as they shall determine, including the granting of options, warrants or conversion or other rights to stock.

Section 2.2. Number of Directors; Qualifications. The board of directors shall consist of such number of directors, not less than 3 nor more than 11, as shall be fixed initially by the incorporator(s) and thereafter by the board of directors. No director need be a stockholder.

Section 2.3. Nomination of Directors.

(a) Nominations for the election of directors may be made by the board of directors or by any stockholder entitled to vote for the election of directors. Nominations by stockholders shall be made by notice in writing, delivered or mailed by first class United States mail, postage prepaid, to the secretary of the corporation not less than 45 days nor more than 60 days prior to any meeting of the stockholders called for the election of directors.

(b) Each notice under subsection (a) shall set forth (i) the name, age, business address and, if known, residence address of each nominee proposed in such notice, (ii) the principal occupation or employment of each such nominee, and (iii) the number of shares of stock of the corporation which are beneficially owned by each such nominee.

(c) The chairman of the meeting of stockholders may, if the facts warrant, determine and declare to the meeting that a nomination was not made in accordance with the foregoing procedure, and if he should so determine, he shall so declare to the meeting and the defective nomination shall be disregarded.

Section 2.4. Election of Directors. The initial board of directors shall be elected by the incorporator(s) at the first meeting thereof and thereafter by the stockholders at their annual meeting or at any special meeting the notice of which specifies the election of directors as an item of business for such meeting.

Section 2.5. Vacancies; Reduction of the Board. Any vacancy in the board of directors, however occurring, including a vacancy resulting from the enlargement of the board of directors, may be filled by the stockholders or by the directors then in office or by a sole remaining director. In lieu of filling any such vacancy the stockholders or board of directors may reduce the number of directors, but not to a number less than 3. When one or more directors shall resign from the board of directors, effective at a future date, a majority of the directors then in office, including those who have so resigned, shall have power to fill such vacancy or vacancies, the vote thereon to take effect when such resignation or resignations shall become effective.

Section 2.6. Enlargement of the Board. The board of directors may be enlarged by the stockholders at any meeting or by vote of a majority of the directors then in office.

4

Section 2.7. Tenure and Resignation. Except as otherwise provided by law, by the Certificate of Incorporation or by these By-laws, directors shall hold office until the next annual meeting of stockholders and thereafter until their successors are chosen and qualified. Any director may resign by delivering or mailing postage prepaid a written resignation to the corporation at its principal office or to the chairman of the board of directors, president, secretary or assistant secretary, if any. Such resignation shall be effective upon receipt unless it is specified to be effective at some other time or upon the happening of some other event.

Section 2.8. Removal. A director, whether elected by the stockholders or directors, may be removed from office only for cause, either at any annual or any special meeting of stockholders, by vote of a majority of the stockholders entitled to vote in the election of such directors, or to the extent permitted by law, by a vote of a majority of the directors then in office; provided, however, that a director may be removed for cause only after reasonable notice and opportunity to be heard before the body proposing to remove him.

Section 2.9. Meetings. Regular meetings of the board of directors may be held without call or notice at such times and such places within or without the State of Delaware as the Board may, from time to time, determine, provided that notice of the first regular meeting following any such determination shall be given to directors absent from such determination. A regular meeting of the board of directors shall be held without notice immediately after, and at the same place as, the annual meeting of the stockholders or the special meeting of the stockholders held in place of such annual meeting, unless a quorum of the directors is not then present. Special meetings of the board of directors may be held at any time and at any place designated in the call of the meeting when called by the president, treasurer, or one or more directors. Members of the board of directors or any committee elected thereby may participate in a meeting of such board or committee by means of a conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other at the same time, and participation by such means shall constitute presence in person at the meeting.

Section 2.10. Notice of Meeting. It shall be sufficient notice to a director to send notice by mail at least seventy-two (72) hours before the meeting addressed to such person at his usual or last known business or residence address or to give notice to such person in person or by telephone at least twenty-four (24) hours before the meeting. Notice shall be given by the secretary, assistant secretary, if any, or by the officer or directors calling the meeting. The requirement of notice to any director may be waived by a written waiver of notice, executed by such person before or after the meeting or meetings, and filed with the records of the meeting, or by attendance at the meeting without protesting prior thereto or at its commencement the lack of notice. A notice or waiver of notice of a directors' meeting need not specify the purposes of the meeting.

Section 2.11. Agenda. Any lawful business may be transacted at a meeting of the board of directors, notwithstanding the fact that the nature of the business may not have been specified in the notice or waiver of notice of the meeting.

5

Section 2.12. Quorum. At any meeting of the board of directors, a majority of the directors then in office shall constitute a quorum for the transaction of business. Any meeting may be adjourned by a majority of the votes cast upon the question, whether or not a quorum is present, and the meeting may be held as adjourned without further notice.

Section 2.13. Action at Meeting. Any motion adopted by vote of the majority of the directors present at a meeting at which a quorum is present shall be the act of the board of directors, except where a different vote is required by law, by the Certificate of Incorporation or by these By-laws. The assent in writing of any director to any vote or action of the directors taken at any meeting, whether or not a quorum was present and whether or not the director had or waived notice of the meeting, shall have the same effect as if the director so assenting was present at such meeting and voted in favor of such vote or action.

Section 2.14. Action Without Meeting. Any action by the directors may be taken without a meeting if all of the directors consent to the action in writing and the consents are filed with the records of the directors' meetings. Such consent shall be treated for all purposes as a vote of the directors at a meeting.

Section 2.15. Committees. The board of directors may, by the affirmative vote of a majority of the directors then in office, appoint an executive committee or other committees consisting of one or more directors and may by vote delegate to any such committee some or all of their powers except those which by law, the Certificate of Incorporation or these By-laws they may not delegate. Unless the board of directors shall otherwise provide, any such committee may make rules for the conduct of its business, but unless otherwise provided by the board of directors or such rules, its meetings shall be called, notice given or waived, its business conducted or its action taken as nearly as may be in the same manner as is provided in these By-laws with respect to meetings or for the conduct of business or the taking of actions by the board of directors. The board of directors shall have power at any time to fill vacancies in, change the membership of, or discharge any such committee at any time. The board of directors shall have power to rescind any action of any committee, but no such rescission shall have retroactive effect.

ARTICLE III.

Officers

Section 3.1. Enumeration. The officers shall consist of a chairman of the board of directors, president, executive vice-president, a treasurer, a secretary and such other officers and agents (including one or more additional vice-presidents, assistant treasurers and assistant secretaries), as the board of directors may, in their discretion, determine.

6

Section 3.2. Election. The chairman of the board of directors, president, executive vice-president, treasurer and secretary shall be elected annually by the directors at their first meeting following the annual meeting of the stockholders or any special meeting held in lieu of the annual meeting. Other officers may be chosen by the directors at such meeting or at any other meeting.

Section 3.3. Qualification. An officer may, but need not, be a director or stockholder. Any two or more offices may be held by the same person. Any officer may be required by the directors to give bond for the faithful performance of his duties to the corporation in such amount and with such sureties as the directors may determine. The premiums for such bonds may be paid by the corporation.

Section 3.4. Tenure. Except as otherwise provided by the Certificate of Incorporation or these By-laws, the term of office of each officer shall be for one year or until his successor is elected and qualified or until his earlier resignation or removal.

Section 3.5. Removal. Any officer may be removed from office, with or without cause, by the affirmative vote of a majority of the directors then in office; provided, however, that an officer may be removed for cause only after reasonable notice and opportunity to be heard by the board of directors prior to action thereon.

Section 3.6. Resignation. Any officer may resign by delivering or mailing postage prepaid a written resignation to the corporation at its principal office or to the chairman of the board of directors, president, secretary, or assistant secretary, if any, and such resignation shall be effective upon receipt unless it is specified to be effective at some other time or upon the happening of some event.

Section 3.7. Vacancies. A vacancy in any office arising from any cause may be filled for the unexpired portion of the term by the board of directors.

Section 3.8. Chairman of the Board. The chairman of the board of directors shall be the chief executive officer of the corporation and shall have such duties and powers as are commonly incident to such office, and shall have such other duties and powers as the board of directors may from time to time determine. He shall preside at all meetings of the board of directors.

Section 3.9. President. The president shall be the chief operating officer of the corporation. Except as otherwise voted by the board of directors, the president shall preside at all meetings of the stockholders, and at meetings of the board of directors in the absence of the chairman of the board. The president shall have such duties and powers as are commonly incident to the office of chief operating officer and such duties and powers as the board of directors shall from time to time designate.

7

Section 3.10. Executive Vice-President; Vice-President(s). In the absence of either the chairman of the board of directors or the president, the executive vice-president shall have and may exercise all of the powers of the officer who is absent. The executive vice-president and any additional vice- presidents, shall have such other powers and perform such duties as the board of directors may from time to time determine.

Section 3.11. Treasurer and Assistant Treasurers. The treasurer, subject to the direction and under the supervision and control of the board of directors, shall have general charge of the financial affairs of the corporation. The treasurer shall have custody of all funds, securities and valuable papers of the corporation, except as the board of directors may otherwise provide. The treasurer shall keep or cause to be kept full and accurate records of account which shall be the property of the corporation, and which shall be always open to the inspection of each elected officer and director of the corporation. The treasurer shall deposit or cause to be deposited all funds of the corporation in such depository or depositories as may be authorized by the board of directors. The treasurer shall have the power to endorse for deposit or collection all notes, checks, drafts, and other negotiable instruments payable to the corporation. The treasurer shall perform such other duties as are incidental to the office, and such other duties as may be assigned by the board of directors.

Assistant treasurers, if any, shall have such powers and perform such duties as the board of directors may from time to time determine.

Section 3.12. Secretary and Assistant Secretaries. The secretary shall record, or cause to be recorded, all proceedings of the meetings of the stockholders and directors (including committees thereof) in the book of records of this corporation. The record books shall be open at reasonable times to the inspection of any stockholder, director, or officer. The secretary shall notify the stockholders and directors, when required by law or by these By-laws, of their respective meetings, and shall perform such other duties as the directors and stockholders may from time to time prescribe. The secretary shall have the custody and charge of the corporate seal, and shall affix the seal of the corporation to all instruments requiring such seal, and shall certify under the corporate seal the proceedings of the directors and of the stockholders, when required. In the absence of the secretary at any such meeting, a temporary secretary shall be chosen who shall record the proceedings of the meeting in the aforesaid books.

Assistant secretaries, if any, shall have such powers and perform such duties as the board of directors may from time to time designate.

Section 3.13. Other Powers and Duties. Subject to these By-laws and to such limitations as the board of directors may from time to time prescribe, the officers of the corporation shall each have such powers and duties as generally pertain to their respective offices, as well as such powers and duties as from time to time may be conferred by the board of directors.

8

ARTICLE IV.

Capital Stock

Section 4.1. Stock Certificates. Each stockholder shall be entitled to a certificate representing the number of shares of the capital stock of the corporation owned by such person in such form as shall, in conformity to law, be prescribed from time to time by the board of directors. Each certificate shall be signed by the chairman of the board of directors, the president or any vice- president and by the secretary, assistant secretary or treasurer or assistant treasurer, or such other officers designated by the board of directors from time to time as permitted by law, shall bear the seal of the corporation, and shall express on its face its number, date of issue, class, the number of shares for which, and the name of the person to whom, it is issued. The corporate seal and any or all of the signatures of corporation officers may be facsimile if the stock certificate is manually counter-signed by an authorized person on behalf of a transfer agent or registrar other than the corporation or its employee.

If an officer, transfer agent or registrar who has signed, or whose facsimile signature has been placed on, a certificate shall have ceased to be such before the certificate is issued, it may be issued by the corporation with the same effect as if he were such officer, transfer agent or registrar at the time of its issue.

Section 4.2. Transfer of Shares. Title to a certificate of stock and to the shares represented thereby shall be transferred only on the books of the corporation by delivery to the corporation or its transfer agent of the certificate properly endorsed, or by delivery of the certificate accompanied by a written assignment of the same, or a properly executed written power of attorney to sell, assign or transfer the same or the shares represented thereby. Upon surrender of a certificate for the shares being transferred, a new certificate or certificates shall be issued according to the interests of the parties.

Section 4.3. Record Holders. Except as otherwise may be required by law, by the Certificate of Incorporation or by these By-laws, the corporation shall be entitled to treat the record holder of stock as shown on its books as the owner of such stock for all purposes, including the payment of dividends and the right to vote with respect thereto, regardless of any transfer, pledge or other disposition of such stock, until the shares have been transferred on the books of the corporation in accordance with the requirements of these By-laws.

It shall be the duty of each stockholder to notify the corporation of his post office address.

Section 4.4. Record Date. In order that the corporation may determine the stockholders entitled to receive notice of or to vote at any meeting of stockholders or any adjournments thereof, or to express consent to corporate action in writing without a meeting, or entitled to receive payment of any dividend or other distribution or allotment of any rights, or entitled to exercise any rights in respect of any change, conversion or exchange of stock or for the purpose

9

of any other lawful action, the board of directors may fix, in advance, a record date, which shall not be more than sixty days prior to any other action. In such case only stockholders of record on such record date shall be so entitled notwithstanding any transfer of stock on the books of the corporation after the record date.

If no record date is fixed: (i) the record date for determining stockholders entitled to receive notice of or to vote at a meeting of stockholders shall be at the close of business on the day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held; (ii) the record date for determining stockholders entitled to express consent to corporate action in writing without a meeting, when no prior action by the board of directors is necessary, shall be the day on which the first written consent is expressed; and (iii) the record date for determining stockholders for any other purpose shall be at the close of business on the day on which the board of directors adopts the resolution relating thereto.

Section 4.5. Transfer Agent and Registrar for Shares of Corporation.
The board of directors may appoint a transfer agent and a registrar of the certificates of stock of the corporation. Any transfer agent so appointed shall maintain, among other records, a stockholders' ledger, setting forth the names and addresses of the holders of all issued shares of stock of the corporation, the number of shares held by each, the certificate numbers representing such shares, and the date of issue of the certificates representing such shares. Any registrar so appointed shall maintain, among other records, a share register, setting forth the total number of shares of each class of shares which the corporation is authorized to issue and the total number of shares actually issued. The stockholders' ledger and the share register are hereby identified as the stock transfer books of the corporation; but as between the stockholders' ledger and the share register, the names and addresses of stockholders, as they appear on the stockholders' ledger maintained by the transfer agent shall be the official list of stockholders of record of the corporation. The name and address of each stockholder of record, as they appear upon the stockholders' ledger, shall be conclusive evidence of who are the stockholders entitled to receive notice of the meetings of stockholders, to vote at such meetings, to examine a complete list of the stockholders entitled to vote at meetings, and to own, enjoy and exercise any other property or rights deriving from such shares against the corporation. Stockholders, but not the corporation, its directors, officers, agents or attorneys, shall be responsible for notifying the transfer agent, in writing, of any changes in their names or addresses from time to time, and failure to do so will relieve the corporation, its other stockholders, directors, officers, agents and attorneys, and its transfer agent and registrar, of liability for failure to direct notices or other documents, or pay over or transfer dividends or other property or rights, to a name or address other than the name and address appearing in the stockholders' ledger maintained by the transfer agent.

Section 4.6. Loss of Certificates. In case of the loss, destruction or mutilation of a certificate of stock, a replacement certificate may be issued in place thereof upon such terms as the board of directors may prescribe, including, in the discretion of the board of directors, a requirement of bond and indemnity to the corporation.

10

Section 4.7. Restrictions on Transfer. Every certificate for shares of stock which are subject to any restriction on transfer, whether pursuant to the Certificate of Incorporation, the By-laws or any agreement to which the corporation is a party, shall have the fact of the restriction noted conspicuously on the certificate and shall also set forth on the face or back either the full text of the restriction or a statement that the corporation will furnish a copy to the holder of such certificate upon written request and without charge.

Section 4.8. Multiple Classes of Stock. The amount and classes of the capital stock and the par value, if any, of the shares, shall be as fixed in the Certificate of Incorporation. At all times when there are two or more classes of stock, the several classes of stock shall conform to the description and the terms and have the respective preferences, voting powers, restrictions and qualifications set forth in the Certificate of Incorporation and these By-laws. Every certificate issued when the corporation is authorized to issue more than one class or series of stock shall set forth on its face or back either (i) the full text of the preferences, voting powers, qualifications and special and relative rights of the shares of each class and series authorized to be issued, or (ii) a statement of the existence of such preferences, powers, qualifications and rights, and a statement that the corporation will furnish a copy thereof to the holder of such certificate upon written request and without charge.

ARTICLE V.

Dividends

Section 5.1. Declaration of Dividends. Except as otherwise required by law or by the Certificate of Incorporation, the board of directors may, in its discretion, declare what, if any, dividends shall be paid from the surplus or from the net profits of the corporation upon the stock of the corporation; provided, however, that no dividend shall be declared or paid the payment of which would diminish the amount of the paid-in capital of the corporation. Dividends may be paid in cash, in property, in shares of the corporation's stock, or in any combination thereof. Dividends shall be payable upon such dates as the board of directors may designate.

Section 5.2. Reserves. Before the payment of any dividend and before making any distribution of profits, the board of directors, from time to time and in its absolute discretion, shall have power to set aside out of the surplus or net profits of the corporation such sum or sums as the board of directors deems proper and sufficient as a reserve fund to meet contingencies or for such other purpose as the board of directors shall deem to be in the best interests of the corporation, and the board of directors may modify or abolish any such reserve.

11

ARTICLE VI.

Powers of Officers to Contract

With the Corporation

Any and all of the directors and officers of the corporation, notwithstanding their official relations to it, may enter into and perform any contract or agreement of any nature between the corporation and themselves, or any and all of the individuals from time to time constituting the board of directors of the corporation, or any firm or corporation in which any such director may be interested, directly or indirectly, whether such individual, firm or corporation thus contracting with the corporation shall thereby derive personal or corporate profits or benefits or otherwise; provided, that (i) the material facts of such interest are disclosed or are known to the board of directors or committee thereof which authorizes such contract or agreement; (ii) if the material facts as to such person's relationship or interest are disclosed or are known to the stockholders entitled to vote thereon, and the contract is specifically approved in good faith by a vote or the stockholders; or (iii) the contract or agreement is fair as to the corporation as of the time it is authorized, approved or ratified by the board of directors, a committee thereof, or the stockholders. Any director of the corporation who is interested in any transaction as aforesaid may nevertheless be counted in determining the existence of a quorum at any meeting of the board of directors which shall authorize or ratify any such transaction. This Article shall not be construed to invalidate any contract or other transaction which would otherwise be valid under the common or statutory law applicable thereto.

ARTICLE VII

Indemnification

Section 7.1. Definitions. For purposes of this Article VII the following terms shall have the meanings indicated:

(a) "Code of Conduct" means the corporation's Code of Conduct for Directors, Officers and Employees as in effect from time to time.

(b) "Corporate Status" describes the status of a person who is or was a director, officer, employee, agent, trustee or fiduciary of the Corporation or of any other corporation, partnership, joint venture, trust, employee benefit plan or other Enterprise which such person is or was serving at the express written request of the corporation.

(c) "Court" means the Court of Chancery of the State of Delaware, the court in which the Proceeding in respect of which indemnification is sought by a Covered Person shall have been brought or is pending, or another court having subject jurisdiction and personal jurisdiction over the parties.

12

(d) "Covered Person" means a person who is a present or former director or officer of the corporation and shall include such person's legal representatives, heirs, executors and administrators.

(e) "Disinterested Director" means a director of the corporation who is not and was not a party to the Proceeding in respect of which indemnification is sought by a Covered Person.

(f) "Enterprise" shall mean the corporation and any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise of which a Covered Person is or was serving at the express written request of the corporation as a director, officer, employee, agent, trustee or fiduciary.

(g) "Expenses" shall include, without limitation, all reasonable attorneys' fees, retainers, court costs, transcript costs, fees of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, and all other disbursements or expenses of the types customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating or being or preparing to be a witness in a Proceeding.

(h) "Good Faith" shall mean a Covered Person having acted in good faith and in a manner such Covered Person reasonably believed to be in or not opposed to the best interests of the corporation or, in the case of an Enterprise which is an employee benefit plan, the best interests of the participants or beneficiaries of said plan, as the case may be, and, with respect to any Proceeding which is criminal in nature, having had no reasonable cause to believe such Covered Person's conduct was unlawful.

(i) "Independent Counsel" means a law firm, or a member of a law firm, that is experienced in matters of corporation law and may include law firms or members thereof that are regularly retained by the corporation but not any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term "Independent Counsel" shall not include any person who, under the standards of professional conduct then prevailing and applicable to such counsel, would have a conflict of interest in representing either the corporation or Covered Person in an action to determine Covered Person's rights under this Article.

(j) "Proceeding" includes any action, suit, arbitration, alternate dispute resolution mechanism, investigation (including any internal corporate investigation), administrative hearing or any other actual, threatened or completed proceeding whether civil, criminal, administrative or investigative, other than one initiated by the Covered Person. For purposes of the foregoing sentence, a "Proceeding" shall not be deemed to have been initiated by the Covered Person where such Covered Person seeks to enforce such Covered Person's rights under this Article.

13

Section 7.2. Right to Indemnification in General.

(a) Covered Persons. In connection with any Proceeding, the corporation shall indemnify, and advance Expenses, to each Covered Person as provided in this Article and to the fullest extent permitted by applicable law in effect on the date hereof and to such greater extent as applicable law may hereafter from time to time permit. The indemnification provisions in this Article shall be deemed to be a contract between the corporation and each Covered Person who serves in any such Corporate Status at any time while these provisions as well as the relevant provisions of the Delaware General Corporation Law are in effect and any repeal or modification thereof shall not affect any right or obligation then existing with respect to any state of facts then or previously existing or any Proceeding previously or thereafter brought or threatened based in whole or in part upon any such state of facts. Such a "contract right" may not be modified retroactively without the consent of such Covered Person.

(b) Employees and Agents. The corporation may, to the extent authorized from time to time by the board of directors, grant indemnification and the advancement of Expenses to any employee or agent of the corporation to the fullest extent of the provisions of this Article with respect to the indemnification and advancement of Expenses of Covered Person.

Section 7.3. Proceedings Other Than Proceedings by or in the Right of
the Corporation. Each Covered Person shall be entitled to the rights of indemnification provided in this Section 7.3 if, by reason of such Covered Person's Corporate Status, such Covered Person is, or is threatened to be made, a party to or is otherwise involved in any Proceeding, other than a Proceeding by or in the right of the corporation. Each Covered Person shall be indemnified against Expenses, judgments, penalties, fines and amounts paid in settlements, actually and reasonably incurred by such Covered Person or on such Covered Person's behalf in connection with such Proceeding or any claim, issue or matter therein, if such Covered Person did not violate the corporation's Code of Conduct and acted in Good Faith. Notwithstanding the foregoing, if such Covered Person shall have been found to have violated the corporation's Code of Conduct then in effect, the corporation may, to the extent authorized by the board of directors, indemnify such Covered Person against Expenses, judgments, penalties, fines and amounts paid in settlement, actually and reasonably incurred by such Covered Person or on such Covered Person's behalf.

Section 7.4. Proceedings by or in the Right of the Corporation.

(a) Each Covered Person shall be entitled to the rights of indemnification provided in this Section 7.4 if, by reason of such Covered Person's Corporate Status, such Covered Person is, or is threatened to be made, a party to or is otherwise involved in any Proceeding brought by or in the right of the corporation to procure a judgment in its favor. Such Covered Person shall be indemnified against Expenses, judgments, penalties, and amounts paid in settlement, actually and reasonably incurred by such Covered Person or on such Covered Person's behalf in connection with such Proceeding if such Covered Person acted in Good

14

Faith. Notwithstanding the foregoing, no such indemnification shall be made in respect of any claim, issue or matter in such Proceeding as to which such Covered Person shall have been adjudged to be liable to the corporation if applicable law prohibits such indemnification; provided, however, that, if applicable law so permits, indemnification shall nevertheless be made by the corporation in such event if and only to the extent that the Court which is considering the matter shall determine.

(b) Notwithstanding any provision to the contrary in this Section, if the board of directors, Independent Counsel or the stockholders, as the case may be, making the determination with respect to indemnification as provided under
Section 7.9 hereof, or the Court considering the matter determines that the act or omission which forms the basis for the claim which is the subject of the Proceeding violated the corporation's Code of Conduct then in effect, then, notwithstanding that fact, the corporation may, to the extent authorized by the board of directors, indemnify such Covered Person against all Expenses, judgments, penalties and amounts paid in settlement, actually and reasonably incurred by such Covered Person or on such Covered Person's behalf in connection with such proceeding if such Covered Person acted in Good Faith.

Section 7.5. Indemnification of a Party Who is Wholly or Partly
Successful. Notwithstanding any other provision of this Article, to the extent that a Covered Person is, by reason of such Covered Person's Corporate Status, a party to or is otherwise involved in and is successful, on the merits or otherwise, in any Proceeding, such Covered Person shall be indemnified to the maximum extent permitted by law, against all Expenses, judgments, penalties, fines, and amounts paid in settlement, actually and reasonably incurred by such Covered Person or on such Covered Person's behalf in connection therewith. If such Covered Person is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the corporation shall indemnify such Covered Person to the maximum extent permitted by law, against all Expenses, judgments, penalties, fines, and amounts paid in settlement, actually and reasonably incurred by such Covered Person or on such Covered Person's behalf in connection with each successfully resolved claim, issue or matter. For purposes of this Section 7.5 and without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter.

Section 7.6. Indemnification for Expenses of a Witness. Notwithstanding any other provision of this Article, to the extent that a Covered Person is, by reason of such Covered Person's Corporate Status, a witness in any Proceeding, such Covered Person shall be indemnified against all Expenses actually and reasonably incurred by such Covered Person or on such Covered Person's behalf in connection therewith.

Section 7.7. Advancement of Expenses. Notwithstanding any provision to the contrary in this Article, the corporation (acting through the chairman of the board, president, executive vice president or any vice president of the corporation) shall advance all reasonable Expenses which, by reason of a Covered Person's Corporate Status, were incurred by or on behalf of such

15

Covered Person in connection with any Proceeding, within twenty (20) days after the receipt by the corporation of a statement or statements from such Covered Person requesting such advance or advances, whether prior to or after final disposition of such Proceeding. Such statement or statements shall reasonably evidence the Expenses incurred by the Covered Person and shall include or be preceded or accompanied by an undertaking by or on behalf of the Covered Person to repay any Expenses if it shall ultimately be determined that such Covered Person is not entitled to be indemnified against such Expenses. Any advance and undertakings to repay pursuant to this Section 7.7 shall be unsecured and interest free. Advancement of Expenses pursuant to this Section 7.7 shall not require approval of the board of directors or the stockholders of the corporation, or of any other person or body. The Secretary of the corporation shall promptly advise the Board in writing of the request for advancement of Expenses, of the amount and other details of the advance and of the undertaking to make repayment pursuant to this Section 7.7.

Section 7.8. Notification and Defense of Claim. Promptly after receipt by an Covered Person of notice of the commencement of any Proceeding, such Covered Person shall, if a claim is to be made against the corporation under this Article, notify the corporation of the commencement of the Proceeding. The omission so to notify the corporation will not relieve it from any liability which it may have to such Covered Person otherwise than under this Article. With respect to any such Proceedings to which such Covered Person notifies the corporation:

(a) The corporation will be entitled to participate in the defense at its own expense.

(b) Except as otherwise provided below, the corporation jointly with any other indemnifying party similarly notified will be entitled to assume the defense with counsel reasonably satisfactory to the Covered Person. After notice from the corporation to the Covered Person of its election to assume the defense of a suit, the corporation will not be liable to the Covered Person under this Article for any legal or other expenses subsequently incurred by the Covered Person in connection with the defense of the Proceeding other than reasonable costs of investigation or as otherwise provided below. The Covered Person shall have the right to employ his own counsel in such Proceeding but the fees and expenses of such counsel incurred after notice from the corporation of its assumption of the defense shall be at the expense of the Covered Person unless
(i) the employment of counsel by the Covered Person has been authorized by the corporation, (ii) the Covered Person shall have concluded reasonably that there may be a conflict of interest between the corporation and the Covered Person in the conduct of the defense of such action and such conclusion is confirmed in writing by the corporation's outside counsel regularly employed by it in connection with corporate matters, or (iii) the corporation shall not in fact have employed counsel to assume the defense of such Proceeding, in each of which cases the fees and expenses of counsel shall be at the expense of the corporation. The corporation shall not be entitled to assume the defense of any Proceeding brought by or in the right of the corporation or as to which the Covered Person shall have made the conclusion provided for in (ii) above and such conclusion shall have been so confirmed by the corporation's said outside counsel.

16

(c) Notwithstanding any provision of this Article to the contrary, the corporation shall not be liable to indemnify the Covered Person under this Article for any amounts paid in settlement of any Proceeding or claim effected without its written consent. The corporation shall not settle any Proceeding or claim in any manner which would impose any penalty, limitation or disqualification of the Covered Person for any purpose without such Covered Person's written consent. Neither the corporation nor the Covered Person will unreasonably withhold their consent to any proposed settlement.

(d) If it is determined that the Covered Person is entitled to indemnification not covered by defense of the claim afforded under subparagraph
(b) above, payment to the Covered Person of the additional amounts to be indemnified shall be made within ten (10) days after determination.

Section 7.9. Method of Determination. A determination (if required by applicable law in the specific case) with respect to a Covered Person's entitlement to indemnification shall be made (a) by the board of directors by a majority vote of a quorum consisting of Disinterested Directors, or (b) in the event that a quorum of the Board consisting of Disinterested Directors is not obtainable or, even if obtainable, such quorum of Disinterested Directors so directs, by Independent Counsel in a written opinion to the board of directors, a copy of which shall be delivered to the Covered Person seeking indemnification, or (c) by the holders of a majority of the votes of the outstanding stock at the time entitled to vote on matters other than the election or removal of directors, voting as a single class, including the stock of the Covered Person seeking indemnification.

Section 7.10. Presumptions and Effect of Certain Proceedings.

(a) Burden of Proof. In making a determination with respect to entitlement to indemnification hereunder, the person or persons or entity making such determination shall presume that the Covered Person is entitled to indemnification under this Article if such Covered Person has submitted a request for indemnification including such documentation and information as is reasonably available to such Covered Person and is reasonably necessary to determine whether and to what extent such Covered Person is entitled to indemnification and the corporation shall have the burden of proof to overcome that presumption in connection with the making by any person, persons or entity of any determination contrary to that presumption.

(b) Effect of Other Proceedings. The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of guilty or of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Article) of itself adversely affect the right of an Covered Person to indemnification or create a presumption that an Covered Person violated the corporation's Code of Conduct or did not act in Good Faith.

17

(c) Actions of Others. The knowledge and/or actions, or failure to act, of any director, officer, employee, agent, trustee or fiduciary of the Enterprise shall not be imputed to a Covered Person for purposes of determining the right to indemnification under this Article.

Section 7.11. Non-Exclusivity. The rights of indemnification and to receive advancement of Expenses as provided by this Article shall not be deemed exclusive of any other rights to which a Covered Person may at any time be entitled under applicable law, the Certificate of Incorporation, these By-Laws, any agreement, a vote of stockholders or a resolution of the board of directors, or otherwise. No amendment, alteration, rescission or replacement of this Article or any provision hereof shall be effective as to an Covered Person with respect to any action taken or omitted by such Covered Person in such Covered Person's Corporate Status prior to such amendment, alteration, rescission or replacement.

Section 7.12. Insurance. The corporation may maintain, at its expense, an insurance policy or policies to protect itself and any Covered Person, officer, employee or agent of the corporation or another Enterprise against liability arising out of this Article or otherwise, whether or not the corporation would have the power to indemnify any such person against such liability under the Delaware General Corporation Law.

Section 7.13. No Duplicative Payment. The corporation shall not be liable under this Article to make any payment of amounts otherwise indemnifiable hereunder if and to the extent that a Covered Person has otherwise actually received such payment under any insurance policy, contract, agreement or otherwise.

Section 7.14. Severability. If any provision or provisions of this Article shall be held to be invalid, illegal or unenforceable for any reason whatsoever:

(a) the validity, legality and enforceability of the remaining provisions of this Article (including without limitation, each portion of any Section of this Article containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby; and

(b) to the fullest extent possible, the provisions of this Article (including, without limitation, each portion of any Section of this Article containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested by the provision held invalid, illegal or unenforceable.

18

ARTICLE VIII.

Miscellaneous Provisions

Section 8.1. Certificate of Incorporation. All references in these By- laws to the Certificate of Incorporation shall be deemed to refer to the Certificate of Incorporation of the corporation, as amended and in effect from time to time.

Section 8.2. Fiscal Year. Except as from time to time otherwise provided by the board of directors, the fiscal year of the corporation shall end on the 31st day of March of each year.

Section 8.3. Corporate Seal. The board of directors shall have the power to adopt and alter the seal of the corporation.

Section 8.4. Execution of Instruments. All deeds, leases, transfers, contracts, bonds, notes, and other obligations authorized to be executed by an officer of the corporation on its behalf shall be signed by the chairman of the board of directors, the president or the treasurer except as the board of directors may generally or in particular cases otherwise determine.

Section 8.5. Voting of Securities. Unless the board of directors otherwise provides, the chairman of the board of directors, the president or the treasurer may waive notice of and act on behalf of this corporation, or appoint another person or persons to act as proxy or attorney in fact for this corporation with or without discretionary power and/or power of substitution, at any meeting of stockholders or shareholders of any other corporation or organization, any of whose securities are held by this corporation.

Section 8.6. Evidence of Authority. A certificate by the secretary or any assistant secretary as to any action taken by the stockholders, directors or any officer or representative of the corporation shall, as to all persons who rely thereon in good faith, be conclusive evidence of such action. The exercise of any power which by law, by the Certificate of Incorporation, or by these By- laws, or under any vote of the stockholders or the board of directors, may be exercised by an officer of the corporation only in the event of absence of another officer or any other contingency shall bind the corporation in favor of anyone relying thereon in good faith, whether or not such absence or contingency existed.

Section 8.7. Corporate Records. The original, or attested copies, of the Certificate of Incorporation, By-laws, records of all meetings of the incorporators and stockholders, and the stock transfer books (which shall contain the names of all stockholders and the record address and the amount of stock held by each) shall be kept in Delaware at the principal office of the corporation, or at an office of the corporation, or at an office of its transfer agent or of the secretary or of the assistant secretary, if any. Said copies and records need not all be kept in the same office. They shall be available at all reasonable times to inspection of any stockholder for any purpose but not to secure a list of stockholders for the purpose of selling said list or copies

19

thereof or for using the same for a purpose other than in the interest of the applicant, as a stockholder, relative to the affairs of the corporation.

Section 8.8. Charitable Contributions. The board of directors from time to time may authorize contributions to be made by the corporation in such amounts as it may determine to be reasonable to corporations, trusts, funds or foundations organized and operated exclusively for charitable, scientific or educational purposes, no part of the net earning of which inures to the private benefit of any stockholder or individual.

ARTICLE IX.

Amendments

Section 9.1. Amendment by Stockholders. Prior to the issuance of stock, these By-laws may be amended, altered or repealed by the incorporator(s) by majority vote. After stock has been issued, these By-laws may be amended altered or repealed by the stockholders at any annual or special meeting by vote or a majority of all shares outstanding and entitled to vote, except that where the effect of the amendment would be to reduce any voting requirement otherwise required by law, the Certificate of Incorporation or these By-laws, such amendment shall require the vote that would have been required by such provision. Notice and a copy of any proposal to amend these By-laws must be included in the notice of meeting of stockholders at which action is taken upon such amendment.

Section 9.2. Amendment by Board of Directors. These By-laws may be amended or altered by the board of directors at a meeting duly called for the purpose by majority vote of the directors then in office, except that directors shall not amend the By-laws in a manner which:

(a) changes the stockholder voting requirements for any action;

(b) alters or abolishes any preferential right or right of redemption applicable to a class or series of stock with shares already outstanding;

(c) alters the provisions of this Article IX hereof; or

(d) permits the board of directors to take any action which under law, the Certificate of Incorporation, or these By-laws is required to be taken by the stockholders.

Any amendment of these By-laws by the board of directors may be altered or repealed by the stockholders at any annual or special meeting of stockholders.

20

ABIOMED, INC.

1989 NON-QUALIFIED STOCK OPTION PLAN

FOR NON-EMPLOYEE DIRECTORS

As Amended July 2, 1990 ,August 17, 1992 and June 15, 1995

1. Purpose. The purpose of this 1989 Non-Qualified Stock Option Plan for Non-Employee Directors is to attract and retain the services of experienced and knowledgeable independent directors of the Corporation for the benefit of the Corporation and its stockholders and to provide additional incentives for such independent directors to continue to work for the best interests of the Corporation and its stockholders through continuing ownership of its common stock.

2. Definitions. As used herein, each of the following terms has the indicated meaning:

"Corporation" means ABIOMED, Inc.

"Fair Market Value" means the last sale price of the Shares as reported on the American Stock Exchange or such other national securities exchange or the National Association of Securities Dealers Automated Quotation System ("NASDAQ") on which the Shares may be traded on the date of the granting of the Option or if that day is not a business day on the last business date preceding the date of grant.

"Option" means the contractual right to purchase Shares upon the specific terms set forth in this Plan.

"Option Exercise Period" means the period commencing on the date of grant of an Option pursuant to this Plan and ending ten years from the date of grant.

"Plan" means this ABIOMED, Inc. 1989 Non-Qualified Stock Option Plan for Non-Employee Directors.

"Shares" means the Common Stock, $.01 par value, of the Corporation.

3. Stock Subject to the Plan. The aggregate number of Shares that may be issued and sold under the Plan shall be 200,000 shares. The Shares to be issued upon exercise of Options granted under this Plan shall be made available, at the discretion of the Board of Directors, from (i) treasury Shares and/or Shares reacquired by the Corporation for such purposes, including Shares purchased in the open market, (ii) authorized but unissued Shares, and (iii) Shares previously reserved for issuance upon exercise of Options which have expired or been terminated. If any Option granted under this Plan shall expire or terminate for any reason without having been exercised in full, the unpurchased Shares covered thereby shall become available for grant under additional Options under the Plan so long as it shall remain in effect.

4. Administration of the Plan. The Plan shall be administered by the Board of Directors of the Corporation (the "Board"). The Board shall, subject to the provisions of the

Plan, grant options under the Plan and shall have the power to construe the Plan, to determine all questions as to eligibility, and to adopt and amend such rules and regulations for the administration of the Plan as it may deem desirable. The Board may delegate any and all of its authority hereunder to one or more Committees of the Board.

5. Eligibility; Grant of Options. Options will be granted only to directors of the Corporation who are not otherwise employees of the Corporation and who do not own or are not affiliated with any person who owns, directly or indirectly, shares of the Corporation's stock having more than five percent of the vote of the Corporation's outstanding voting stock ("Eligible Directors"). Each Eligible Director shall be granted an option to acquire 12,500 Shares commencing (i) with respect to each Newly Elected Director on the date he or she is elected to the Board and (ii) with respect to all other Eligible Directors August 17, 1992. Thereafter each Eligible Director shall be granted a new option for 12,500 Shares on July 1 of each successive fifth year following the grant of his or her initial 12,500 Share Option.

6. Terms of Options and Limitations Thereon.

(a) Option Agreement. Each Option granted under this Plan shall be evidenced by an option agreement between the Corporation and the Option holder and shall be upon such terms and conditions not inconsistent with this Plan as the Board may determine. Each Option shall explicitly state that it is not intended to be an "incentive stock option" as that term is defined in Section 422A of the Internal Revenue Code.

(b) Price. The price at which any Shares may be purchased pursuant to the exercise of an Option shall be the Fair Market Value of the Shares on the date of grant, but in no event shall the price be less than the par value of the Shares.

(c) Exercise of Options. Subject to Paragraph 7 of this Plan, each Option granted under this Plan may be exercised in full at one time or in part from time to time only during the Option Exercise Period by the giving of written notice, signed by the person or persons exercising the Option, to the Corporation stating the numbers of Shares with respect to which the Option is being exercised, accompanied by full payment for such Shares pursuant to section 7(b) hereof; provided however, (i) if a person to whom an Option has been granted is permanently disabled or dies during the Option Exercise Period, the portion of such Option then exercisable, as provided in Paragraph 7(a) shall be exercisable by him or her or by the executors, administrators, legatees or distributees of his or her estate during the 12 months following his or her or death or permanent disability and, (ii) if a person to whom an Option has been granted ceases to be an Eligible Director of the Corporation for any cause other than death or permanent disability, the portion of Option then exercisable shall be exercisable during the thirty (30) day period following the date such person ceased to be a non-employee director, but, in any event, only to the extent vested pursuant to Paragraph 7(a) hereof.

(d) Non-Assignability. No Option or right or interest in an Option shall be assignable or transferable by the holder except by will or the laws of descent and distribution and during the lifetime of the holder shall be exercisable only by him or her.

-2-

7. Vesting; Payment.

(a) Subject to the right of the Corporation to accelerate the date on which all or any portion of the Option becomes exercisable and to the provisions of subsection (b) below, each Option holder's right to exercise any Option granted hereunder shall vest in five equal cumulative installments of twenty (20%) percent of the number of shares subject to the Option each, commencing on the June 30 following the date of grant with an additional twenty (20%) percent vesting each successive June 30 thereafter. Notwithstanding any provision of this Agreement to the contrary, in no event may the Option be exercised after ten years from the date of this Agreement (the "Expiration Date").

(b) If one of the events referred to in clauses (i) and (ii) of Paragraph 6(c) occurs, the Option shall be exercisable during the specified period following said permanent disability or death only as to the number of Shares as to which it was exercisable immediately prior to said permanent disability or death.

(c) The purchase price of Shares upon exercise of an Option shall be paid by the Option holder in full upon exercise and may be paid (i) in cash,
(ii) by delivery of Shares having a Fair Market Value on the date of exercise equal to the purchase price, or (iii) any combination of cash and Shares, as the Board may determine.

(d) No Shares shall be issued or transferred upon exercise of any Option under this Plan unless and until all legal requirements applicable to the issuance or transfer of such shares and such other requirements as are consistent with the Plan have been complied with to the satisfaction of the Board, including without limitation those described in Paragraph 10 hereof.

8. Stock Adjustments.

(a) If the Corporation is a party to any merger or consolidation, any purchase or acquisition of property or stock, or any separation, reorganization or liquidation, the Board (or, if the Corporation is not the surviving corporation, the Board of Directors of the surviving corporation) shall have the power to make arrangements, which shall be binding upon the holders of unexpired Options, for the substitution of new options for, or the assumption by another corporation of, any unexpired Options then outstanding hereunder.

(b) If by reason of recapitalization, reclassification, stock split- up, combination of shares, separation (including a spin-off) or dividend on the Stock payable in Shares, the outstanding Shares of the Corporation are increased or decreased or changed into or exchanged for a different number or kind of shares or other securities of the Corporation, the Board shall conclusively determine the appropriate adjustment in the exercise prices of outstanding Options and in the number and kind of shares as to which outstanding Options shall be exercisable.

(c) In the event of a transaction of the type described in Paragraphs
(a) and (b) above, the total number of Shares on which Options may be granted under this Plan shall be appropriately adjusted by the Board.

9. No Rights Other Than Those Expressly Created. No person affiliated with the Corporation or other person shall have any claim or right to be granted an Option hereunder. Neither this Plan nor any action taken hereunder shall be construed as (i) giving any Option

-3-

holder any right to continue to be affiliated with the Corporation, (ii) giving any Option holder any equity or interest of any kind in any assets of the Corporation, or (iii) creating a trust of any kind or a fiduciary relationship of any kind between the Corporation and any such person. No Option holder shall have any of the rights of a stockholder with respect to Shares covered by an Option until such time as the Option has been exercised and Shares have been issued to such person.

10. Miscellaneous.

(a) Withholding of Taxes. Pursuant to applicable federal, state, local or foreign laws, the Corporation may be required to collect income or other taxes upon the grant of an Option to, or exercise of an Option by, a holder. The Corporation may require, as a condition to the exercise of an Option, that the recipient pay the Corporation, at such time as the Board determines, the amount of any taxes which the Board may determine is required to be withheld.

(b) Securities Law Compliance. Upon exercise of an Option, the holder shall be required to make such representations and furnish such information as may, in the opinion of counsel for the Corporation, be appropriate to permit the Corporation to issue or transfer the Shares in compliance with the provisions of applicable federal or state securities laws. The Corporation, in its discretion, may postpone the issuance and delivery of Shares upon any exercise of an Option until completion of such registration or other qualification of such Shares under any federal or state laws, or stock exchange listing, as the Corporation may consider appropriate. The Corporation is not obligated to register or qualify the Shares under federal or state securities laws and may refuse to issue such Shares if neither registration nor exemption therefrom is practical. The Board may require that prior to the issuance or transfer of any Shares upon exercise of an Option, the recipient enter into a written agreement to comply with any restrictions on subsequent disposition that the Board or the Corporation deems necessary or advisable under any applicable federal and state securities laws. Certificates representing the Shares issued hereunder may be legended to reflect such restrictions.

(c) Indemnity. The Board shall not be liable for any act, omission, interpretation, construction or determination made in good faith in connection with its responsibilities with respect to the Plan, and the Corporation hereby agrees to indemnify the members of the Board, in respect of any claim, loss, damage, or expense (including counsel fees) arising from any such act, omission, interpretation, construction or determination to the full extent permitted by law.

11. Effective Date; Amendment; Termination.

(a) The effective date of this Plan is September 6, 1989. The effective date of any amendment of this Plan shall be the date such amendment is adopted by the Board of Directors, subject to stockholder approval if required under subsection (b).

(b) The Board, or any Committee who has been delegated the authority to do so, may at any time, and from time to time, amend, suspend or terminate this Plan in whole or in part. Provided however, that so long as there is a requirement under Rule 16b-3 under the Securities Exchange Act of 1934, as amended, for stockholder approval of a Plan and certain amendments thereto, any such amendment which (i) materially increases the number of Shares which may be subject to Options granted under the Plan, (ii) materially increases the benefits accruing to participants in the Plan, or (iii) materially modifies the requirement for eligibility to

-4-

participate in the Plan, shall be subject to stockholder approval, to the extent so required under said Rule; and provided further that the Plan may not be modified more often than once every six months to materially modify (i) the requirements for eligibility under the Plan, (ii) the timing of the grants of Options under the Plan, (iii) the number of Shares subject to Options to be granted under the Plan, or (iv) the formula for determining the fair market value, other than to comport with changes in the Internal Revenue Code, the Employee Retirement Income Security Act, or the rules thereunder. Except as provided herein, no amendment, suspension or termination of this Plan may adversely affect the rights of any person under an Option that has been granted to such person without such person's consent.

(c) This Plan shall terminate ten years from its effective date, and no Option shall be granted under this Plan thereafter, but such termination shall not affect the validity of Options granted prior to the date of termination.

Date of Board of Director Adoption: July 10, 1989 as amended on July 2, 1990, August 17, 1992 and June 15, 1995.

-5-

ABIOMED, Inc.

1992 COMBINATION STOCK OPTION PLAN, AS AMENDED

Preamble. Combination and Modification of Original Plans.

WHEREAS, the Stockholders and Directors of ABIOMED, Inc. (the "Corporation") approved (A) the Incentive Stock Option Plan, as amended and restated on June 22, 1988 and further amended by Amendment No. 1 and Amendment No. 2 thereto (the "Original Incentive Stock Option Plan"), and (B) the Non- Qualified Stock Option Plan, as amended and restated June 22, 1988 and further amended by Amendment No. 1, Amendment No. 2 and Amendment No. 3 thereto (the "Original Non-Qualified Stock Option Plan") for the purpose of issuing stock options to purchase the Corporation's stock; and

WHEREAS, pursuant to the Original Incentive Stock Option Plan and the Original Non-Qualified Plan (collectively, the "Original Plans"), the Board of Directors now desire to combine and amend and restate the Original Plans as set forth herein;

NOW THEREFORE, the Corporation hereby combines and amends and restates the Original Plans to be in the form of this 1992 Combination Stock Option Plan (hereafter, the term "1992 Plan" includes both this amended and restated plan and each of the Original Plans, as adopted and originally amended, as applicable).

Section I. Purpose of the Plan.

The purposes of the 1992 Plan are (i) to provide long-term incentives and rewards to those employees (the "Employee Participants") of ABIOMED, Inc. (the "Corporation") and its subsidiaries (if any), and any other persons (the "Non- employee Participants") who are in a position to contribute to the long-term success and growth of the Corporation and its subsidiaries, (ii) to assist the Corporation in retaining and attracting executives and employees with requisite experience and ability, and (iii) to associate more closely the interests of such executives and key employees with those of the Corporation's stockholders. Notwithstanding the foregoing, a Director of the Corporation who either (i) is not an employee of the Corporation or (ii) is, or within the past year was, a member of a committee designated by the Board of Directors of the Corporation to administer the 1992 Plan shall not be eligible to receive any options under the 1992 Plan, and shall not be included in the definition of "Non-employee Participants" or "Employee Participants".

-1-

Section II. Definitions.

"Code" is the Internal Revenue Code of 1986, as it may be amended from

time to time.

"Common Stock" is the $.01 par value common stock of the Corporation.

"Committee" is defined in Section III, paragraph (a).

"Corporation" is defined in Section I.

"Corporation ISOs" are all stock options (including 1992 Plan ISOs) which (i) are Incentive Stock Options and (ii) are granted under any plans (including this 1992 Plan and the Original Incentive Stock Option Plan) of the Corporation, a Parent Corporation and/or a Subsidiary Corporation.

"Employee Participants" are defined in Section I.

"Fair Market Value" of any property is the value of the property as reasonably determined by the Committee.

"Incentive Stock Option" is a stock option which is treated as an incentive stock option under Section 422 of the Code.

"1934 Act" means the Securities Exchange Act of 1934, as amended, or any successor or similar statute.

"1992 Plan" is defined in the Preamble.

"1992 Plan ISOs" are Stock Options which are Incentive Stock Options.

"Non-employee Participants" are defined in Section I.

"Non-qualified Option" is a Stock Option which does not qualify as an Incentive Stock Option or for which the Committee provides, in the terms of such option and at the time such option is granted, that the option shall not be treated as an Incentive Stock Option.

"Original Incentive Stock Option Plan" is defined in the Preamble.

"Original Non-Qualified Stock Option Plan" is defined in the Preamble.

"Parent Corporation" has the meaning provided in Section 425(e) of the

Code.

-2-

"Participants" are all persons who are either Employee Participants or

Non-employee Participants.

"Permanent and Total Disability" has the meaning provided in Section

22(e)(3) of the Code.

"Stockholder Approval" means the affirmative vote of at least a majority of the shares of Common Stock present and entitled to vote at a duly held meeting of the stockholders of the Corporation, unless a greater vote is required by state law, or the rules under Section 16 of the 1934 Act, if applicable to the Corporation, in which case such greater requirement shall apply. Stockholder approval may be obtained by written consent or other means, to the extent permitted by applicable state law.

"Stock Options" are rights granted pursuant to this 1992 Plan to purchase shares of Common Stock at a fixed price.

"Subsidiary Corporation" has the meaning provided in Section 425(f) of

the Code.

"Ten Percent Stockholder" means, with respect to a 1992 Plan ISO, any individual who directly or indirectly owns stock possessing more than 10% of the total combined voting power of all classes of stock of the Corporation or any Parent Corporation or any Subsidiary Corporation at the time such 1992 Plan ISO is granted.

Section III. Administration.

(a) The Committee. The Plan shall be administered by the Board of Directors of the Corporation, or if the Board so determines, by a Compensation Committee designated by the Board of Directors of the Corporation (the administering body is hereafter referred to as the "Committee"). No person shall be eligible to be a member of the Committee if that person's membership would prevent the plan from complying with Section 16 of the 1934 Act or rules adopted thereunder, if applicable to the Corporation. The Committee shall serve at the pleasure of the Board of Directors, which may from time to time, and in its sole discretion, discharge any member, appoint additional new members in substitution for those previously appointed and/or fill vacancies however caused. A majority of the Committee shall constitute a quorum and the acts of a majority of the members present at any meeting at which a quorum is present shall be deemed the action of the Committee.

(b) Authority and Discretion of the Committee. Subject to the express provisions of this 1992 Plan and provided that all actions taken shall be consistent with the purposes of this 1992 Plan, and subject to ratification by the Board of Directors only if required by applicable law, the Committee shall have full and complete authority and the sole discretion to: (i) determine those persons who shall constitute employees eligible to be Employee Participants; (ii) select the

-3-

Participants to whom Stock Options shall be granted under this 1992 Plan; (iii) determine the size and the form of the Stock Options, if any, to be granted to any Participant; (iv) determine the time or times such Stock Options shall be granted including the grant of Stock Options in connection with other awards made, or compensation paid, to the Participant; (v) establish the terms and conditions upon which such Stock Options may be exercised and/or transferred, including the exercise of Stock Options in connection with other awards made, or compensation paid, to the Participant; (vi) make or alter any restrictions and conditions upon such Stock Options and the Stock received on exercise thereof, including, but not limited to, providing for limitations on the Participant's right to keep any Stock received on termination of employment; and (vii) adopt such rules and regulations, establish, define and/or interpret these and any other terms and conditions, and make all determinations (which may be on a case- by-case basis) deemed necessary or desirable for the administration of this 1992 Plan. Notwithstanding any provision of this 1992 Plan to the contrary, only Employee Participants shall be eligible to receive 1992 Plan ISOs.

(c) Applicable Law. This 1992 Plan, and all Stock Options shall be governed by the law of the state in which the Corporation is incorporated.

Section IV. Terms of Stock Options.

(a) Agreements. Stock Options shall be evidenced by a written agreement between the Corporation and the Participant awarded the Stock Option. Said agreement shall be in such form, and contain such terms and conditions (not inconsistent with this 1992 Plan) as the Committee may determine. If the Stock Option described therein is not intended to be an Incentive Stock Option, but otherwise qualifies as an Incentive Stock Option, such agreement shall include the following, or a similar, statement: "This stock option is not intended to be an Incentive Stock Option, as that term is described in Section 422 of the Internal Revenue Code of 1986, as amended."

(b) Term. Stock Options shall be for such periods as may be determined

by the Committee, provided that in the case of 1992 Plan ISOs, the term of any such 1992 Plan ISO shall not extend beyond three months after the time the Participant ceases to be an employee of the Corporation. Notwithstanding the foregoing, the Committee may provide in a 1992 Plan ISO that in the event of the Permanent and Total Disability or death of the Participant, the 1992 Plan ISO may be exercised by the Participant or his estate (if applicable) for a period of up to one year after the date of such Permanent and Total Disability or Death. In no event may a 1992 Plan ISO be exercisable (including provisions, if any, for exercise in installments) subsequent to ten years after the date of grant, or, in the case of 1992 Plan ISOs granted to Ten Percent Stockholders, more than five years after the date of grant.

(c) Purchase Price. The purchase price of shares purchased pursuant to any Stock Option shall be determined by the Committee, and shall be paid by the Participant or other person permitted to exercise the Stock Option in full upon exercise, (i) in cash, (ii) by delivery of shares

-4-

of Common Stock (valued at their Fair Market Value on the date of such exercise), (iii) any other property (valued at its Fair Market Value on the date of such exercise), or (iv) any combination of cash, stock and other property, with any payment made pursuant to subparagraphs (ii), (iii) or (iv) only as permitted by the Committee, in its sole discretion. In no event will the purchase price of Common Stock be less than the par value of the Common Stock. Furthermore the purchase price of Common Stock subject to a 1992 Plan ISO shall not be less than the Fair Market Value of the Common Stock on the date of the issuance of the 1992 Plan ISO, provided that in the case of 1992 Plan ISOs granted to Ten Percent Stockholders, the purchase price shall not be less than 110% of the Fair Market Value of the Common Stock on the date of issuance of the 1992 Plan ISO.

(d) Further Restrictions as to Incentive Stock Options. To the extent that the aggregate Fair Market Value of Common Stock with respect to which Corporation ISOs (determined without regard to this section) are exercisable for the first time by any Employee Participant during any calendar year exceeds $100,000, such Corporation ISOs shall be treated as options which are not Incentive Stock Options. For the purpose of this limitation, options shall be taken into account in the order granted, and the Committee may designate that portion of any Corporation ISO that shall be treated as not an Incentive Stock Option in the event that the provisions of this paragraph apply to a portion of any option, unless otherwise required by the Code or regulations of the Internal Revenue Service. The designation described in the preceding sentence may be made at such time as the Committee considers appropriate, including after the issuance of the option or at the time of its exercise. For the purpose of this section, Fair Market Value shall be determined as of the time the option with respect to such stock is granted.

(e) Restrictions. At the discretion of the Committee, the Common Stock issued pursuant to the Stock Options granted hereunder may be subject to restrictions on vesting or transfer ability. For the purposes of this limitation, options shall be taken into account in the order granted.

(f) Withholding of Taxes. Pursuant to applicable federal, state, local or foreign laws, the Corporation may be required to collect income or other taxes upon the grant of a Stock Option to, or exercise of a Stock Option by, a holder. The Corporation may require, as a condition to the exercise of a Stock Option, or demand, at such other time as it may consider appropriate, that the Participant pay the Corporation the amount of any taxes which the Corporation may determine is required to be withheld or collected, and the Participant shall comply with the requirement or demand of the Corporation. In its discretion, the Corporation may withhold shares to be received upon exercise of a Stock Option if it deems this an appropriate method for withholding or collecting taxes.

(g) Securities Law Compliance. Upon exercise (or partial exercise) of a Stock Option, the Participant or other holder of the Stock Option shall make such representations and furnish such information as may, in the opinion of counsel for the Corporation, be appropriate to permit the Corporation to issue or transfer Stock in compliance with the provisions of applicable federal or

-5-

state securities laws. The Corporation, in its discretion, may postpone the issuance and delivery of Stock upon any exercise of this Option until completion of such registration or other qualification of such shares under any federal or state laws, or stock exchange listing, as the Corporation may consider appropriate. Furthermore, the Corporation is not obligated to register or qualify the shares of Common Stock to be issued upon exercise of a Stock Option under federal or state securities laws (or to register or qualify them at any time thereafter), and it may refuse to issue such shares if, in its sole discretion, registration or exemption from registration is not practical or available. The Corporation may require that prior to the issuance or transfer of Stock upon exercise of a Stock Option, the Participant enter into a written agreement to comply with any restrictions on subsequent disposition that the Corporation deems necessary or advisable under any applicable federal and state securities laws. Certificates of Stock issued hereunder may bear a legend reflecting such restrictions.

(h) Right to Stock Option. No employee of the Corporation or any other person shall have any claim or right to be a participant in this 1992 Plan or to be granted a Stock Option hereunder. Neither this 1992 Plan nor any action taken hereunder shall be construed as giving any person any right to be retained in the employ of the Corporation. Nothing contained hereunder shall be construed as giving any person any equity or interest of any kind in any assets of the Corporation or creating a trust of any kind or a fiduciary relationship of any kind between the Corporation and any such person. As to any claim for any unpaid amounts under this 1992 Plan, any person having a claim for payments shall be an unsecured creditor.

(i) Indemnity. Neither the Board of Directors nor the Committee, nor any members of either, nor any employees of the Corporation or any parent, subsidiary, or other affiliate, shall be liable for any act, omission, interpretation, construction or determination made in good faith in connection with their responsibilities with respect to this 1992 Plan, and the Corporation hereby agrees to indemnify the members of the Board of Directors, the members of the Committee, and the employees of the Corporation and its parent or subsidiaries in respect of any claim, loss, damage, or expense (including reasonable counsel fees) arising from any such act, omission, interpretation, construction or determination to the full extent permitted by law.

(j) Participation by Foreigners. Without amending this 1992 Plan, except to the extent required by the Code in the case of Incentive Stock Options, the Committee may modify grants made to participants who are foreign nationals or employed outside the United States so as to recognize differences in local law, tax policy, or custom.

Section V. Amendment and Termination; Adjustments Upon Changes in Stock.

(a) Amendment. The Board of Directors of the Corporation may at any time, and from time to time, amend, suspend or terminate this 1992 Plan in whole or in part; provided, however, that neither the Board of Directors nor the Committee may amend or modify the definition of Employee Participants, materially increase the benefits accruing to Participants, increase the

-6-

number of shares of Common Stock reserved for purposes of this 1992 Plan, extend the term of this 1992 Plan, materially modify the requirements to be a Participant in this 1992 Plan, or otherwise modify the Plan in any way or manner requiring the approval of the Stockholders under the Code or Section 16 of the 1934 Act, if applicable to the Corporation, or rules and regulations thereunder, without Stockholder Approval and compliance with any applicable law, rules, or regulations. Except as provided herein, no amendment, suspension or termination of this 1992 Plan may affect the rights of a Participant to whom a Stock Option has been granted without such Participant's consent.

(b) Discretion to Convert ISO's. The Committee is specifically authorized to convert, in its discretion, the unexercised portion of any 1992 Plan ISO granted to an Employee Participant to a Non-qualified Option at any time prior to the exercise, in full, of such 1992 Plan ISO.

(c) Adjustments upon Changes in Stock. If there shall be any change in the Common Stock or to any Stock Option granted under this 1992 Plan through merger, consolidation, reorganization, recapitalization, stock dividend, stock split or other change in the corporate structure of the Corporation, appropriate adjustments may be made by the Board of Directors of the Corporation or the Committee (or if the Corporation is not the surviving corporation in any such transaction, the Board of Directors of the surviving corporation) in the aggregate number and kind of shares subject to this 1992 Plan, and the number and kind of shares and the price per share subject to outstanding options, provided that such adjustment does not affect the qualification of any 1992 Plan ISO as an Incentive Stock Option. In connection with the foregoing, the Board of Directors or the Committee may issue new Stock Options in exchange for outstanding Stock Options.

Section VI. Shares of Stock Subject to the Plan.

The number of shares of Common Stock that may be the subject of awards under this 1992 Plan shall not exceed an aggregate of 1,300,000 shares, including shares of Common Stock that were the subject of awards under the Original Incentive Stock Option Plan and the Original Non-Qualified Stock Option Plan. Shares to be delivered under this 1992 Plan may be either authorized but unissued shares of Common Stock or treasury shares. Any shares subject to an Option hereunder which for any reason terminates, is cancelled or otherwise expires unexercised, shall, at such time, no longer count towards the aggregate number of shares which have been the subject of Stock Options issued hereunder, and such number of shares shall be subject to further awards under this 1992 Plan, provided the total number of shares then eligible for award under this 1992 Plan may not exceed the total specified in the first sentence of this
Section VI.

-7-

Section VII. Effective Date and Term of this Plan.

Provided there is Stockholder Approval on or before December 31, 1992, the effective date of this 1992 Plan is May 1, 1992 (the "Effective Date") and awards under this 1992 Plan may be made for a period of ten years commencing on the Effective Date. The period during which a Stock Option may be exercised may extend beyond that time as provided herein.

-8-

ARTICLE 5


PERIOD TYPE 3 MOS 6 MOS
FISCAL YEAR END MAR 31 1996 MAR 31 1996
PERIOD START JUL 01 1995 APR 01 1995
PERIOD END SEP 30 1995 SEP 30 1995
CASH 333,775 333,775
SECURITIES 9,483,593 9,483,593
RECEIVABLES 2,440,415 2,440,415
ALLOWANCES (99,644) (99,644)
INVENTORY 1,253,351 1,253,351
CURRENT ASSETS 13,651,344 13,651,344
PP&E 2,691,713 2,691,713
DEPRECIATION 2,218,449 2,218,449
TOTAL ASSETS 15,485,606 15,485,606
CURRENT LIABILITIES 1,931,891 1,931,891
BONDS 0 0
COMMON 69,418 69,418
PREFERRED MANDATORY 0 0
PREFERRED 0 0
OTHER SE 13,484,297 13,484,297
TOTAL LIABILITY AND EQUITY 15,485,606 15,485,606
SALES 3,106,599 5,850,089
TOTAL REVENUES 3,106,599 5,850,089
CGS 1,768,054 3,341,806
TOTAL COSTS 1,768,054 3,341,806
OTHER EXPENSES 1,414,585 2,631,499
LOSS PROVISION 0 0
INTEREST EXPENSE 124,488 255,725
INCOME PRETAX 48,448 132,509
INCOME TAX 0 0
INCOME CONTINUING 48,448 132,509
DISCONTINUED 0 0
EXTRAORDINARY 0 0
CHANGES 0 0
NET INCOME 48,448 132,509
EPS PRIMARY .007 .019
EPS DILUTED .007 .019